Drug	Alternate_Formulation	Formulatioin_Synonyms	Reformat Drug	Reformat Fromulation Synonym
17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521		(4-(2-Hydroxy-2-methylpropyl)piperidin-1-yl)(5-methoxy-1H-indol-2-yl)methanone || 17bHSD5 Inhibitor ASP9521 || 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521 || ASP 9521 || ASP9521	17BETAHYDROXYSTEROIDDEHYDROGENASETYPE5INHIBITORASP9521	METHANONE||17BHSD5INHIBITORASP9521||17BETAHYDROXYSTEROIDDEHYDROGENASETYPE5INHIBITORASP9521||ASP9521||ASP9521
2-Hydroxyoleic Acid		2-Hydroxyoleic Acid || 2-OHOA || 2OHOA || Minerval	2HYDROXYOLEICACID	2HYDROXYOLEICACID||2OHOA||2OHOA||MINERVAL
"2,6-Dimethoxyquinone"		"2,5-Cyclohexadiene-1,4-Dione, 2,6-Dimethoxy- || 2,5-Cyclohexadiene-1,4-Dione, 2,6-Dimethoxy- (9CI) || 2,6-DMBQ || 2,6-Dimethoxy-1,4-Benzoquinone || 2,6-Dimethoxy-p-Benzoquinone || 2,6-Dimethoxy-p-Quinone || 2,6-Dimethoxybenzoquinone || 2,6-Dimethoxycyclohexa-2,5-Diene-1,4-Dione || 2,6-Dimethoxyquinone || 2,6-Dimethoxyquinone || p-Benzoquinone, 2,6-Dimethoxy-"	"2,6DIMETHOXYQUINONE"	"2,5CYCLOHEXADIENE1,4DIONE,2,6DIMETHOXY||2,5CYCLOHEXADIENE1,4DIONE,2,6DIMETHOXY||2,6DMBQ||2,6DIMETHOXY1,4BENZOQUINONE||2,6DIMETHOXYPBENZOQUINONE||2,6DIMETHOXYPQUINONE||2,6DIMETHOXYBENZOQUINONE||2,6DIMETHOXYCYCLOHEXA2,5DIENE1,4DIONE||2,6DIMETHOXYQUINONE||2,6DIMETHOXYQUINONE||PBENZOQUINONE,2,6DIMETHOXY"
Abemaciclib		"2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl) || ABEMACICLIB || Abemaciclib || LY-2835219 || LY2835219 || Verzenio"	ABEMACICLIB	"2PYRIMIDINAMINE,N||ABEMACICLIB||ABEMACICLIB||LY2835219||LY2835219||VERZENIO"
Abemaciclib	Abemaciclib Mesylate 	ABEMACICLIB MESYLATE || Abemaciclib Mesylate || LY-2835219 Methanesulfonate || LY-2835219 methanesulfonate	ABEMACICLIBMESYLATE	ABEMACICLIBMESYLATE||ABEMACICLIBMESYLATE||LY2835219METHANESULFONATE||LY2835219METHANESULFONATE
Abiraterone		"17-(3-Pyridyl)androsta-5,16-dien-3beta-ol || ABIRATERONE || Abiraterone || Abiraterone || CB 7598"	ABIRATERONE	"17ANDROSTA5,16DIEN3BETAOL||ABIRATERONE||ABIRATERONE||ABIRATERONE||CB7598"
Abiraterone	Abiraterone Acetate	"17-(3-Pyridyl)-5,16-androstadien-3beta-acetate || ABIRATERONE ACETATE || Abiraterone Acetate || Abiraterone Acetate || Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)- || CB7630 || Yonsa || Zytiga || abiraterone acetate"	ABIRATERONEACETATE	17||CB7630||YONSA||ZYTIGA||ABIRATERONEACETATE
Afatinib		(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide || AFATINIB || Afatinib || Afatinib || BIBW 2992 || BIBW2992	AFATINIB	BUT2ENAMIDE||AFATINIB||AFATINIB||AFATINIB||BIBW2992||BIBW2992
Afatinib	Afatinib Dimaleate	"(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate) || 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-, (2Z)-2-Butenedioate (1:2) || AFATINIB DIMALEATE || Afatinib Dimaleate || Afatinib Dimaleate || BIBW 2992MA2 || BIBW2992 MA2 || Gilotrif"	AFATINIBDIMALEATE	||AFATINIBDIMALEATE||AFATINIBDIMALEATE||AFATINIBDIMALEATE||BIBW2992MA2||BIBW2992MA2||GILOTRIF
Akt Inhibitor MK2206		"1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl- || Akt Inhibitor MK2206 || Akt Inhibitor MK2206 || Akt inhibitor MK2206 || MK 2206 FREE BASE || MK-2206 || MK2206 || MK2206"	AKTINHIBITORMK2206	"1,2,4TRIAZOLO9PHENYL||AKTINHIBITORMK2206||AKTINHIBITORMK2206||AKTINHIBITORMK2206||MK2206FREEBASE||MK2206||MK2206||MK2206"
Alectinib		"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo- || AF-802 || AF802 || ALECTINIB || Alecensa || Alecensa || Alectinib || Alectinib || CH5424802 || RG7853 || RO5424802"	ALECTINIB	5HBENZO11OXO||AF802||AF802||ALECTINIB||ALECENSA||ALECENSA||ALECTINIB||ALECTINIB||CH5424802||RG7853||RO5424802
Alisertib		"ALISERTIB || Alisertib || Alisertib || Aurora A Kinase Inhibitor MLN8237 || Benzoic Acid, 4-((9-Chloro-7-(2-Fluoro-6-Methoxyphenyl)-5H-Pyrimido(5,4-d)(2)Benzazepin-2-yl)Amino)-2-Methoxy- || MLN-8237 || MLN8237"	ALISERTIB	"ALISERTIB||ALISERTIB||ALISERTIB||AURORAAKINASEINHIBITORMLN8237||BENZOICACID,42METHOXY||MLN8237||MLN8237"
ALK Inhibitor TAE684		"5-Chloro-n4-(2-(isopropylsulfonyl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine || ALK Inhibitor TAE684 || NPM-ALK Inhibitor TAE684 || NVP-TAE684 || TAE 684 || TAE-684 || TAE-684 || TAE684"	ALKINHIBITORTAE684	"5CHLORON4PYRIMIDINE2,4DIAMINE||ALKINHIBITORTAE684||NPMALKINHIBITORTAE684||NVPTAE684||TAE684||TAE684||TAE684||TAE684"
Alpelisib		ALPELISIB || Alpelisib || Alpelisib || BYL719 || Phosphoinositide 3-kinase Inhibitor BYL719 || Piqray	ALPELISIB	ALPELISIB||ALPELISIB||ALPELISIB||BYL719||PHOSPHOINOSITIDE3KINASEINHIBITORBYL719||PIQRAY
Alvocidib		"(-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one || ALVOCIDIB || Alvocidib || Alvocidib || Alvocidib || Alvocidib Freebase || Flavopiridol || alvocidib || flavopiridol"	ALVOCIDIB	4H1BENZOPYRAN4ONE||ALVOCIDIB||ALVOCIDIB||ALVOCIDIB||ALVOCIDIB||ALVOCIDIBFREEBASE||FLAVOPIRIDOL||ALVOCIDIB||FLAVOPIRIDOL
Alvocidib	Alvocidib Hydrochloride	"(-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one Hydrochloride || 4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5, 7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, hydrochloride, (-)-cis- || ALVOCIDIB HYDROCHLORIDE || Alvocidib Hydrochloride || Alvocidib Hydrochloride || Flavopiridol Hydrochloride || HL-275 || HMR 1275 || HMR 1275 || L-86-8275 || L-868275 || MDL 107,826A || MDL-107826A"	ALVOCIDIBHYDROCHLORIDE	"CIS||ALVOCIDIBHYDROCHLORIDE||ALVOCIDIBHYDROCHLORIDE||ALVOCIDIBHYDROCHLORIDE||FLAVOPIRIDOLHYDROCHLORIDE||HL275||HMR1275||HMR1275||L868275||L868275||MDL107,826A||MDL107826A"
Alvocidib	Alvocidib Prodrug TP-1287	Alvocidib Phosphate || Alvocidib Phosphate TP-1287 || Alvocidib Prodrug TP-1287 || TP 1287 || TP-1287 || TP1287	ALVOCIDIBPRODRUGTP1287	ALVOCIDIBPHOSPHATE||ALVOCIDIBPHOSPHATETP1287||ALVOCIDIBPRODRUGTP1287||TP1287||TP1287||TP1287
Ambazone		AMBAZONE || Ambazone || Faringosept || p-Benzoquinone Amidinohydrazone Thiosemicarbazone	AMBAZONE	AMBAZONE||AMBAZONE||FARINGOSEPT||PBENZOQUINONEAMIDINOHYDRAZONETHIOSEMICARBAZONE
Anastrozole		"2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile) || ANASTROZOLE || Alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile || Anastrazole || Anastrozole || Anastrozole || Anastrozole || Anastrozole || Arimidex || ICI D1033 || ICI-D1033 || ZD-1033 || anastrozole"	ANASTROZOLE	"2,2'[51,3BENZENEDIACETONITRILE||ANASTRAZOLE||ANASTROZOLE||ANASTROZOLE||ANASTROZOLE||ANASTROZOLE||ARIMIDEX||ICID1033||ICID1033||ZD1033||ANASTROZOLE"
Andrographolide		"(1R-(1-alpha(E(S)),4a-beta,5alpha,6alpha,8a-alpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone || (3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one || (3E,4S)-4-hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one || 2(3H)-Furanone, 3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-, (1R-(1-alpha(E(S*)),4a-beta,5-alpha,6-alpha,8a-alpha))- || 3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one || 3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone || ANDROGRAPHOLIDE || Andrographis || Andrographolide"	ANDROGRAPHOLIDE	",12DIEN16OICACIDGAMMALACTONE||ANDROGRAPHOLIDE||ANDROGRAPHIS||ANDROGRAPHOLIDE"
Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine		Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine || Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine || anti-CTLA-4 mAb Heavy and Light Chain RNA-transfected Autologous DC || antiCTLA4 RNA DC	ANTICTLA4MOABRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE	ANTICTLA4MOABRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE||ANTICTLA4MOABRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE||ANTICTLA4MABHEAVYANDLIGHTCHAINRNATRANSFECTEDAUTOLOGOUSDC||ANTICTLA4RNADC
Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine		Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine || Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine || GITRL/antiCTLA4 RNA DC || anti-CTLA-4 mAb Heavy and Light Chain RNA/GITRL RNA-transfected Autologous DC	ANTICTLA4MOABRNA/GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE	ANTICTLA4MOABRNA/GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE||ANTICTLA4MOABRNA/GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE||GITRL/ANTICTLA4RNADC||ANTICTLA4MABHEAVYANDLIGHTCHAINRNA/GITRLRNATRANSFECTEDAUTOLOGOUSDC
Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202		ADC MORAb-202 || Anti-FRA ADC MORAb-202 || Anti-FRA/Eribulin ADC MORAb-202 || Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202 || Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202 || MORAb 202 || MORAb-202 || MORAb202	ANTIFRA/ERIBULINANTIBODYDRUGCONJUGATEMORAB202	ADCMORAB202||ANTIFRAADCMORAB202||ANTIFRA/ERIBULINADCMORAB202||ANTIFRA/ERIBULINANTIBODYDRUGCONJUGATEMORAB202||ANTIFRA/ERIBULINANTIBODYDRUGCONJUGATEMORAB202||MORAB202||MORAB202||MORAB202
Atezolizumab		"ATEZOLIZUMAB || Atezolizumab || Atezolizumab || Immunoglobulin G1, Anti-(human CD Antigen cd274) (Human Monoclonal MPDL3280A Heavy Chain), Disulfide with Human Monoclonal MPDL3280A Kappa-chain, Dimer || MPDL 3280A || MPDL 328OA || MPDL-3280A || MPDL3280A || MPDL328OA || RG7446 || RO5541267 || Tecentriq"	ATEZOLIZUMAB	"ATEZOLIZUMAB||ATEZOLIZUMAB||ATEZOLIZUMAB||IMMUNOGLOBULING1,ANTI,DISULFIDEWITHHUMANMONOCLONALMPDL3280AKAPPACHAIN,DIMER||MPDL3280A||MPDL328OA||MPDL3280A||MPDL3280A||MPDL328OA||RG7446||RO5541267||TECENTRIQ"
Atrasentan	Atrasentan Hydrochloride	"(+)-A 127722 || (2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid Monohydrochloride || ABT-627 || ATRASENTAN HYDROCHLORIDE || Atrasentan Hydrochloride || Atrasentan Hydrochloride || Xinlay"	ATRASENTANHYDROCHLORIDE	3PYRROLIDINECARBOXYLICACIDMONOHYDROCHLORIDE||ABT627||ATRASENTANHYDROCHLORIDE||ATRASENTANHYDROCHLORIDE||ATRASENTANHYDROCHLORIDE||XINLAY
Aurora Kinase Inhibitor MLN8054		"Aurora Kinase Inhibitor MLN8054 || Benzoic Acid, 4-((9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)- || MLN 8054 || MLN-8054 || MLN8054 || MLN8054"	AURORAKINASEINHIBITORMLN8054	"AURORAKINASEINHIBITORMLN8054||BENZOICACID,4||MLN8054||MLN8054||MLN8054||MLN8054"
Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes		Anti-BCMA-CAR-mRNA-transfected Autologous CD8+ T-cells || Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-cells || Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes || Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes || Autologous Anti-BCMA-CAR-mRNA-transfected CD8-positive T-cells || Descartes-08	AUTOLOGOUSANTIBCMACARMRNATRANSFECTEDCD8+TLYMPHOCYTES	ANTIBCMACARMRNATRANSFECTEDAUTOLOGOUSCD8+TCELLS||AUTOLOGOUSANTIBCMACARMRNATRANSFECTEDCD8+TCELLS||AUTOLOGOUSANTIBCMACARMRNATRANSFECTEDCD8+TLYMPHOCYTES||AUTOLOGOUSANTIBCMACARMRNATRANSFECTEDCD8+TLYMPHOCYTES||AUTOLOGOUSANTIBCMACARMRNATRANSFECTEDCD8POSITIVETCELLS||DESCARTES08
Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells		AGS-003-BLD || Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells || Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells || Autologous DCs Electroporated with Autologous Tumor-derived IVT RNAs/CD40L IVT RNA || Autologous DCs Electroporated with Autologous Tumor-derived RNAs/CD40L RNA || Bladder Cell Carcinoma RNAs/CD40L RNA-transfected Autologous Dendritic Cells	AUTOLOGOUSBLADDERCELLCARCINOMARNAS/CD40LRNAELECTROPORATEDAUTOLOGOUSMATUREDDENDRITICCELLS	AGS003BLD||AUTOLOGOUSBLADDERCELLCARCINOMARNAS/CD40LRNAELECTROPORATEDAUTOLOGOUSMATUREDDENDRITICCELLS||AUTOLOGOUSBLADDERCELLCARCINOMARNAS/CD40LRNAELECTROPORATEDAUTOLOGOUSMATUREDDENDRITICCELLS||AUTOLOGOUSDCSELECTROPORATEDWITHAUTOLOGOUSTUMORDERIVEDIVTRNAS/CD40LIVTRNA||AUTOLOGOUSDCSELECTROPORATEDWITHAUTOLOGOUSTUMORDERIVEDRNAS/CD40LRNA||BLADDERCELLCARCINOMARNAS/CD40LRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLS
Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes		ATLCAR.CD30-CD28zeta-CCR4 Cells || ATLCAR.CD30.CCR4 Cells || ATLs Co-expressing CD30-CARCD28zeta and CCR4 || Anti-CD30-CAR/CD28z-CCR4 Retroviral Vector-transduced Autologous T-Cells || Autologous CCR4-CAR-CD19-CD28-zeta-transduced T-lymphocytes || Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes || Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes || CCR4-CAR-CD30-28zeta-specific Autologous T-cells || SFG.CCR4-CAR.CD30 Autologous T-lymphocytes	AUTOLOGOUSCCR4CD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES	ATLCAR.CD30CD28ZETACCR4CELLS||ATLCAR.CD30.CCR4CELLS||ATLSCOEXPRESSINGCD30CARCD28ZETAANDCCR4||ANTICD30CAR/CD28ZCCR4RETROVIRALVECTORTRANSDUCEDAUTOLOGOUSTCELLS||AUTOLOGOUSCCR4CARCD19CD28ZETATRANSDUCEDTLYMPHOCYTES||AUTOLOGOUSCCR4CD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES||AUTOLOGOUSCCR4CD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES||CCR4CARCD3028ZETASPECIFICAUTOLOGOUSTCELLS||SFG.CCR4CAR.CD30AUTOLOGOUSTLYMPHOCYTES
Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes		ATL-expressing CD30-CAR-CD28zeta || ATLCAR.CD30 Cells || ATLCAR.CD30-CD28zeta Cells || Anti-CD30-CAR/CD28z Retroviral Vector-transduced Autologous T-Cells || Autologous CAR-CD19-CD28-zeta-transduced T-lymphocytes || Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes || Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes || CAR-CD30-28zeta-specific Autologous T-cells || SFG.CAR.CD30 Autologous T-lymphocytes	AUTOLOGOUSCD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES	ATLEXPRESSINGCD30CARCD28ZETA||ATLCAR.CD30CELLS||ATLCAR.CD30CD28ZETACELLS||ANTICD30CAR/CD28ZRETROVIRALVECTORTRANSDUCEDAUTOLOGOUSTCELLS||AUTOLOGOUSCARCD19CD28ZETATRANSDUCEDTLYMPHOCYTES||AUTOLOGOUSCD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES||AUTOLOGOUSCD30CARCD28CD3ZETAEXPRESSINGTLYMPHOCYTES||CARCD3028ZETASPECIFICAUTOLOGOUSTCELLS||SFG.CAR.CD30AUTOLOGOUSTLYMPHOCYTES
Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine		Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine	AUTOLOGOUSHNSCCDNATRANSFECTEDSEMIALLOGENEICFIBROBLASTSMRC5VACCINE	AUTOLOGOUSHNSCCDNATRANSFECTEDSEMIALLOGENEICFIBROBLASTSMRC5VACCINE
Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11		Anti-mesothelin mRNA-transfected Autologous PBMCs MCY-M11 || Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 || Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 || MCY-M11	AUTOLOGOUSMESOTHELINSPECIFICHUMANMRNACARTRANSFECTEDPBMCSMCYM11	ANTIMESOTHELINMRNATRANSFECTEDAUTOLOGOUSPBMCSMCYM11||AUTOLOGOUSMESOTHELINSPECIFICHUMANMRNACARTRANSFECTEDPBMCSMCYM11||AUTOLOGOUSMESOTHELINSPECIFICHUMANMRNACARTRANSFECTEDPBMCSMCYM11||MCYM11
Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine		Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine	AUTOLOGOUSNSCLCDNATRANSFECTEDSEMIALLOGENEICFIBROBLASTSMRC5VACCINE	AUTOLOGOUSNSCLCDNATRANSFECTEDSEMIALLOGENEICFIBROBLASTSMRC5VACCINE
Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine		Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine	AUTOLOGOUSOFAILRPRNATRANSFECTEDDENDRITICCELLVACCINE	AUTOLOGOUSOFAILRPRNATRANSFECTEDDENDRITICCELLVACCINE
Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001		Autologous PBLs IOV-2001 || Autologous PBLs from Ibrutinib-treated CLL Patients || Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 || Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 || IOV 2001 || IOV-2001 || IOV2001	AUTOLOGOUSPERIPHERALBLOODLYMPHOCYTESFROMIBRUTINIBTREATEDCHRONICLYMPHOCYTICLEUKEMIAPATIENTSIOV2001	AUTOLOGOUSPBLSIOV2001||AUTOLOGOUSPBLSFROMIBRUTINIBTREATEDCLLPATIENTS||AUTOLOGOUSPERIPHERALBLOODLYMPHOCYTESFROMIBRUTINIBTREATEDCHRONICLYMPHOCYTICLEUKEMIAPATIENTSIOV2001||AUTOLOGOUSPERIPHERALBLOODLYMPHOCYTESFROMIBRUTINIBTREATEDCHRONICLYMPHOCYTICLEUKEMIAPATIENTSIOV2001||IOV2001||IOV2001||IOV2001
Axitinib		AG-013736 || AG-013736 || AG013736 || AXITINIB || Axitinib || Axitinib || Inlyta || N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide || axitinib	AXITINIB	AG013736||AG013736||AG013736||AXITINIB||AXITINIB||AXITINIB||INLYTA||NMETHYL2BENZAMIDE||AXITINIB
Aziridinylbenzoquinone	Aziridinylbenzoquinone RH1	"2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone || Aziridinylbenzoquinone RH1 || RH1"	AZIRIDINYLBENZOQUINONERH1	"2,5DIAZIRIDINYL36METHYL1,4BENZOQUINONE||AZIRIDINYLBENZOQUINONERH1||RH1"
B-Raf/VEGFR-2 Inhibitor RAF265		B-Raf/VEGFR-2 Inhibitor RAF265 || B-Raf/VEGFR-2 Inhibitor RAF265 || CHIR-265 || CHIR-265 || RAF-265 || RAF265	BRAF/VEGFR2INHIBITORRAF265	BRAF/VEGFR2INHIBITORRAF265||BRAF/VEGFR2INHIBITORRAF265||CHIR265||CHIR265||RAF265||RAF265
Belinostat		BELINOSTAT || Beleodaq || Belinostat || Belinostat || PXD 101 || PXD 101 || PXD101 || PXD101 || belinostat	BELINOSTAT	BELINOSTAT||BELEODAQ||BELINOSTAT||BELINOSTAT||PXD101||PXD101||PXD101||PXD101||BELINOSTAT
Bevacizumab		"Anti-VEGF || Anti-VEGF Humanized Monoclonal Antibody || Anti-VEGF rhuMAb || Avastin || Avastin || BEVACIZUMAB || BP102 || BP102 Biosimilar || Bevacizumab || Bevacizumab || Bevacizumab Biosimilar BEVZ92 || Bevacizumab Biosimilar BI 695502 || Bevacizumab Biosimilar CBT 124 || Bevacizumab Biosimilar CT-P16 || Bevacizumab Biosimilar FKB238 || Bevacizumab Biosimilar GB-222 || Bevacizumab Biosimilar HD204 || Bevacizumab Biosimilar HLX04 || Bevacizumab Biosimilar IBI305 || Bevacizumab Biosimilar LY01008 || Bevacizumab Biosimilar MIL60 || Bevacizumab Biosimilar QL 1101 || Bevacizumab Biosimilar RPH-001 || Bevacizumab Biosimilar SCT501 || Bevacizumab awwb || HD204 || Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer || Recombinant Humanized Anti-VEGF Monoclonal Antibody || SCT501 || bevacizumab || rhuMab-VEGF"	BEVACIZUMAB	"ANTIVEGF||ANTIVEGFHUMANIZEDMONOCLONALANTIBODY||ANTIVEGFRHUMAB||AVASTIN||AVASTIN||BEVACIZUMAB||BP102||BP102BIOSIMILAR||BEVACIZUMAB||BEVACIZUMAB||BEVACIZUMABBIOSIMILARBEVZ92||BEVACIZUMABBIOSIMILARBI695502||BEVACIZUMABBIOSIMILARCBT124||BEVACIZUMABBIOSIMILARCTP16||BEVACIZUMABBIOSIMILARFKB238||BEVACIZUMABBIOSIMILARGB222||BEVACIZUMABBIOSIMILARHD204||BEVACIZUMABBIOSIMILARHLX04||BEVACIZUMABBIOSIMILARIBI305||BEVACIZUMABBIOSIMILARLY01008||BEVACIZUMABBIOSIMILARMIL60||BEVACIZUMABBIOSIMILARQL1101||BEVACIZUMABBIOSIMILARRPH001||BEVACIZUMABBIOSIMILARSCT501||BEVACIZUMABAWWB||HD204||IMMUNOGLOBULING1,DISULFIDEWITHHUMANMOUSEMONOCLONALRHUMABVEGFLIGHTCHAIN,DIMER||RECOMBINANTHUMANIZEDANTIVEGFMONOCLONALANTIBODY||SCT501||BEVACIZUMAB||RHUMABVEGF"
Bevacizumab	Bevacizumab-IRDye 800CW	Bevacizumab-IRDye 800CW	BEVACIZUMABIRDYE800CW	BEVACIZUMABIRDYE800CW
BH3 Mimetic ABT-737		"ABT-737 || ABT-737 || BH3 Mimetic ABT-737 || Benzamide, 4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-n-((4-(((1r)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-"	BH3MIMETICABT737	"ABT737||ABT737||BH3MIMETICABT737||BENZAMIDE,4"
Bicalutamide		"(+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide || 4'-Cyano-alpha,alpha,alpha-trifuloro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide || 4-Cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline || BICALUTAMIDE || Bicalutamide || Bicalutamide || Bicalutamide || Casodex || Cosudex || ICI 176,334 || ICI 176334 || N-[4-Cyano-3-(trifluoromethyl)phenyl]3-3[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-propanamide || bicalutamide"	BICALUTAMIDE	SULFONYL]2HYDROXY2METHYLPROPANAMIDE||BICALUTAMIDE
Birabresib		"6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide, 4-(4-Chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)- || BIRABRESIB || BRD 2/3/4 Inhibitor OTX015 || Birabresib || Birabresib || MK-8628 || OTX015"	BIRABRESIB	6HTHIENO||BIRABRESIB||BRD2/3/4INHIBITOROTX015||BIRABRESIB||BIRABRESIB||MK8628||OTX015
Birinapant		"BIRINAPANT || Birinapant || Birinapant || Propanamide, N,N'-[(6,6'-difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-,(2S,2'S)- || TL32711"	BIRINAPANT	"BIRINAPANT||BIRINAPANT||BIRINAPANT||PROPANAMIDE,N,N'[||TL32711"
Bortezomib		BORTEZOMIB || Bortezomib || Bortezomib || Bortezomib || LDP 341 || MLN341 || PS-341 || PS-341 || PS341 || Velcade || [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid || [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid || bortezomib || velcade	BORTEZOMIB	BORTEZOMIB||BORTEZOMIB||BORTEZOMIB||BORTEZOMIB||LDP341||MLN341||PS341||PS341||PS341||VELCADE||[AMINO]PROPYL]AMINO]BUTYL]BORONICACID||BORTEZOMIB||VELCADE
Bosutinib		"4-Anilino-3-quinolinecarbonitrile || 4-Anilinobenzo(g)quinoline-3-carbonitrile || 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile || BOSUTINIB || Bosulif || Bosutinib || Bosutinib || SKI 606 || SKI-606 || SKI-606"	BOSUTINIB	4ANILINO3QUINOLINECARBONITRILE||4ANILINOBENZOPROPOXY]QUINOLINE3CARBONITRILE||BOSUTINIB||BOSULIF||BOSUTINIB||BOSUTINIB||SKI606||SKI606||SKI606
Bosutinib	Bosutinib Monohydrate	"3-Quinolinecarbonitrile, 4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-, Hydrate (1:1) || BOSUTINIB MONOHYDRATE || Bosulif || Bosutinib Monohydrate || Bosutinib Monohydrate || SKI-606 Monohydrate"	BOSUTINIBMONOHYDRATE	"3QUINOLINECARBONITRILE,4||BOSUTINIBMONOHYDRATE||BOSULIF||BOSUTINIBMONOHYDRATE||BOSUTINIBMONOHYDRATE||SKI606MONOHYDRATE"
Brigatinib		"(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone || 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine || AP 26113 || AP-26113 || AP26113 || Alunbrig || BRIGATINIB || Brigatinib || Brigatinib"	BRIGATINIB	"PIPERIDIN1YL]PHENYL}PYRIMIDINE2,4DIAMINE||AP26113||AP26113||AP26113||ALUNBRIG||BRIGATINIB||BRIGATINIB||BRIGATINIB"
c-Met Inhibitor JNJ-38877605		JNJ-38877605 || c-Met Inhibitor JNJ-38877605	CMETINHIBITORJNJ38877605	JNJ38877605||CMETINHIBITORJNJ38877605
Cabazitaxel		"1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate] || CABAZITAXEL || Cabazitaxel || Cabazitaxel || Jevtana || Jevtana || RPR-116258A || Taxoid XRP6258 || XRP-6258 || cabazitaxel || taxoid XRP6258"	CABAZITAXEL	"1HYDROXY7BETA,10BETADIMETHOXY9OXO5BETA,20EPOXYTAX11ENE2ALPHA,4,13ALPHATRIYL4ACETATE2BENZOATE13[CARBONYL]AMINO}2HYDROXY3PHENYLPROPANOATE]||CABAZITAXEL||CABAZITAXEL||CABAZITAXEL||JEVTANA||JEVTANA||RPR116258A||TAXOIDXRP6258||XRP6258||CABAZITAXEL||TAXOIDXRP6258"
Cabozantinib		"1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- || CABOZANTINIB || Cabozantinib || Cabozantinib || N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide"	CABOZANTINIB	"1,1CYCLOPROPANEDICARBOXAMIDE,N'[4[CYCLOPROPANE1,1DICARBOXAMIDE"
Cabozantinib	Cabozantinib S-malate	"BMS-907351 || Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1) || CABOZANTINIB S-MALATE || Cabometyx || Cabozantinib S-malate || Cabozantinib S-malate || Cometriq || XL-184 || XL184"	CABOZANTINIBSMALATE	"BMS907351||BUTANEDIOICACID,2HYDROXY,||CABOZANTINIBSMALATE||CABOMETYX||CABOZANTINIBSMALATE||CABOZANTINIBSMALATE||COMETRIQ||XL184||XL184"
Caffeic Acid Phenethyl Ester		"2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate || 3-(3,4-Dihydroxyphenyl)-2-propenoic Acid, 2-Phenylethyl Ester || CAFFEIC ACID PHENETHYL ESTER || CAPE || Caffeic Acid Phenethyl Ester || Caffeic Acid Phenethyl Ester"	CAFFEICACIDPHENETHYLESTER	"2PHENYLETHYL32PROPENOICACID,2PHENYLETHYLESTER||CAFFEICACIDPHENETHYLESTER||CAPE||CAFFEICACIDPHENETHYLESTER||CAFFEICACIDPHENETHYLESTER"
Canertinib	Canertinib Dihydrochloride	CANERTINIB DIHYDROCHLORIDE || CI-1033 || CI-1033 || Canertinib Dihydrochloride || Canertinib Dihydrochloride || N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride || N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride || PD-0183805-002B || PD183805 || canertinib || canertinib dihydrochloride	CANERTINIBDIHYDROCHLORIDE	CANERTINIBDIHYDROCHLORIDE||CI1033||CI1033||CANERTINIBDIHYDROCHLORIDE||CANERTINIBDIHYDROCHLORIDE||N[4[PROPOXY]6QUINAZOLINYL]2PROPENAMIDEDIHYDROCHLORIDE||PD0183805002B||PD183805||CANERTINIB||CANERTINIBDIHYDROCHLORIDE
Capecitabine		5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine || CAPECITABINE || Capecitabine || Capecitabine || Capecitabine || Ro 09-1978/000 || Xeloda || Xeloda || capecitabine	CAPECITABINE	5'DEOXY5FLUORON[CARBONYL]CYTIDINE||CAPECITABINE||CAPECITABINE||CAPECITABINE||CAPECITABINE||RO091978/000||XELODA||XELODA||CAPECITABINE
Capecitabine	Capecitabine Rapidly Disintegrating Tablet	Capecitabine RDT || Capecitabine Rapidly Disintegrating Tablet	CAPECITABINERAPIDLYDISINTEGRATINGTABLET	CAPECITABINERDT||CAPECITABINERAPIDLYDISINTEGRATINGTABLET
Carboplatin		"(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum || 1,1-cyclobutanedicarboxylic acid platinum complex || Blastocarb || CARBOPLATIN || CBDCA || CBDCA || Carboplat || Carboplatin || Carboplatin || Carboplatin Hexal || Carboplatino || Carboplatinum || Carbosin || Carbosol || Carbotec || Cis-Diammine(cyclobutane-1,1-dicarboxylato)platinum || Displata || Ercar || JM-8 || Nealorin || Novoplatinum || Paraplat || Paraplatin || Paraplatin || Paraplatin AQ || Paraplatine || Platinwas || Ribocarbo || carboplatin || cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II) || cis-diammine(cyclobutanedicarboxylato)platinum II || platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)"	CARBOPLATIN	
CDK Inhibitor AT7519		AT7519 || AT7519M || AT7519M || CDK Inhibitor AT7519 || CDK inhibitor AT7519M || CDKI AT7519 || Cyclin-Dependent Kinase Inhibitor AT7519M	CDKINHIBITORAT7519	AT7519||AT7519M||AT7519M||CDKINHIBITORAT7519||CDKINHIBITORAT7519M||CDKIAT7519||CYCLINDEPENDENTKINASEINHIBITORAT7519M
CDK Inhibitor R547		CDK Inhibitor R547 || Cyclin Dependent Kinase Inhibitor R547 || Cyclin-Dependent Kinase Inhibitor R547 || R 547 || R-547 || R547 || RO 4584820 || RO-4584820 || RO4584820	CDKINHIBITORR547	CDKINHIBITORR547||CYCLINDEPENDENTKINASEINHIBITORR547||CYCLINDEPENDENTKINASEINHIBITORR547||R547||R547||R547||RO4584820||RO4584820||RO4584820
CDK Inhibitor SNS-032		BMS-387032 || CDK Inhibitor SNS-032 || SNS-032	CDKINHIBITORSNS032	BMS387032||CDKINHIBITORSNS032||SNS032
Cediranib		4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline || AZD2171 || CEDIRANIB || Cediranib || Cediranib	CEDIRANIB	4[PROPOXY]QUINAZOLINE||AZD2171||CEDIRANIB||CEDIRANIB||CEDIRANIB
Cediranib	Cediranib Maleate	"AZD2171 || AZD2171 Maleate || CEDIRANIB MALEATE || Cediranib Maleate || Cediranib Maleate || Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)- || Recentin || Recentin || cediranib maleate"	CEDIRANIBMALEATE	"AZD2171||AZD2171MALEATE||CEDIRANIBMALEATE||CEDIRANIBMALEATE||CEDIRANIBMALEATE||QUINAZOLINE,4||RECENTIN||RECENTIN||CEDIRANIBMALEATE"
Celecoxib		"4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide || Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]- || CELECOXIB || CELECOXIB || Celebrex || Celecoxib || Celecoxib || Celecoxib || SC-58635 || YM 177 || celecoxib"	CELECOXIB	41HPYRAZOL1YL]||CELECOXIB||CELECOXIB||CELEBREX||CELECOXIB||CELECOXIB||CELECOXIB||SC58635||YM177||CELECOXIB
Celecoxib	Topical Celecoxib	Celecoxib Cream || Celecoxib Topical || DFD-07 || DFD07 || Topical Celecoxib	TOPICALCELECOXIB	CELECOXIBCREAM||CELECOXIBTOPICAL||DFD07||DFD07||TOPICALCELECOXIB
Cerdulatinib		CERDULATINIB || Cerdulatinib || PRT-062070 || PRT062070 || Syk-JAK Inhibitor PRT062070 || Syk/JAK Inhibitor PRT062070	CERDULATINIB	CERDULATINIB||CERDULATINIB||PRT062070||PRT062070||SYKJAKINHIBITORPRT062070||SYK/JAKINHIBITORPRT062070
Ceritinib		"2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)- || CERITINIB || Ceritinib || Ceritinib || LDK 378 || LDK378 || Zykadia"	CERITINIB	"2,4PYRIMIDINEDIAMINE,5CHLORON4||CERITINIB||CERITINIB||CERITINIB||LDK378||LDK378||ZYKADIA"
Chaparrinone		"Chaparrinone || Chaparrinone || Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1beta,11beta,12alpha)-"	CHAPARRINONE	"CHAPARRINONE||CHAPARRINONE||PICRAS3ENE2,16DIONE,11,20EPOXY1,11,12TRIHYDROXY,"
Cisplatin	Albumin-binding Cisplatin Prodrug BTP-114	"(SP-4-2)-Diamminedichloroplatinum || Abiplatin || Blastolem || Briplatin || CDDP || CISPLATIN || Cis-diammine-dichloroplatinum || Cis-diamminedichloridoplatinum || Cis-diamminedichloro Platinum (II) || Cis-diamminedichloroplatinum || Cis-dichloroammine Platinum (II) || Cis-platinous Diamine Dichloride || Cis-platinum || Cis-platinum II || Cis-platinum II Diamine Dichloride || Cismaplat || Cisplatin || Cisplatin || Cisplatin || Cisplatin || Cisplatina || Cisplatinum || Cisplatyl || Citoplatino || Citosin || Cysplatyna || DDP || Lederplatin || Metaplatin || Neoplatin || Peyrone's Chloride || Peyrone's Salt || Placis || Plastistil || Platamine || Platiblastin || Platiblastin || Platiblastin-S || Platinex || Platinol || Platinol || Platinol- AQ || Platinol-AQ || Platinol-AQ VHA Plus || Platinoxan || Platinum || Platinum Diamminodichloride || Platinum, Diaminedichloro-, cis- (8CI) || Platiran || Platistin || Platosin || cisplatin"	CISPLATIN	||PLATIRAN||PLATISTIN||PLATOSIN||CISPLATIN
Cisplatin	Albumin-binding Cisplatin Prodrug BTP-114	Albumin-binding Cisplatin Prodrug BTP-114 || Albumin-binding Cisplatin Prodrug BTP-114 || Albumin-conjugating Platinum-prodrug BTP-114 || BTP 114 || BTP-114 || Cisplatin Prodrug BTP-114 || Cisplatin/Maleimide-based Complex BTP-114 || Platinum-Prodrug BTP-114 || Prodrug BTP 114	ALBUMINBINDINGCISPLATINPRODRUGBTP114	ALBUMINBINDINGCISPLATINPRODRUGBTP114||ALBUMINBINDINGCISPLATINPRODRUGBTP114||ALBUMINCONJUGATINGPLATINUMPRODRUGBTP114||BTP114||BTP114||CISPLATINPRODRUGBTP114||CISPLATIN/MALEIMIDEBASEDCOMPLEXBTP114||PLATINUMPRODRUGBTP114||PRODRUGBTP114
Cisplatin	Cisplatin Liposomal	"Cisplatin Liposomal || Cisplatin, Liposomal || Liposomal Cisplatin || SPI-077 || SPI-77 || STEALTH Cisplatin || STEALTH Liposomal Cisplatin || STEALTH Liposomal Encapsulated Cisplatin || STEALTH Liposome Cisplatin"	CISPLATINLIPOSOMAL	"CISPLATINLIPOSOMAL||CISPLATIN,LIPOSOMAL||LIPOSOMALCISPLATIN||SPI077||SPI77||STEALTHCISPLATIN||STEALTHLIPOSOMALCISPLATIN||STEALTHLIPOSOMALENCAPSULATEDCISPLATIN||STEALTHLIPOSOMECISPLATIN"
Cisplatin	Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6	Cisplatin/Vinblastine Formulation with Cell Penetration Enhancer INT230-6 || Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 || Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 || INT 230-6 || INT230-6	CISPLATIN/VINBLASTINE/CELLPENETRATIONENHANCERFORMULATIONINT2306	CISPLATIN/VINBLASTINEFORMULATIONWITHCELLPENETRATIONENHANCERINT2306||CISPLATIN/VINBLASTINE/CELLPENETRATIONENHANCERFORMULATIONINT2306||CISPLATIN/VINBLASTINE/CELLPENETRATIONENHANCERFORMULATIONINT2306||INT2306||INT2306
Cisplatin	Cisplatin-E Therapeutic Implant	CDDP-e therapeutic implant || CDDP/epi || CDDP/epi gel || CEG || Cisplatin-E Therapeutic Implant || Cisplatin-Epinephrine || Cisplatin/Epinephrine Gel || Intradose || Intradose MPI-5010 || MP 5010 TI || MP 5010 Therapeutic Implant || MPI 5010	CISPLATINETHERAPEUTICIMPLANT	CDDPETHERAPEUTICIMPLANT||CDDP/EPI||CDDP/EPIGEL||CEG||CISPLATINETHERAPEUTICIMPLANT||CISPLATINEPINEPHRINE||CISPLATIN/EPINEPHRINEGEL||INTRADOSE||INTRADOSEMPI5010||MP5010TI||MP5010THERAPEUTICIMPLANT||MPI5010
Cisplatin	Sustained-release Lipid Inhaled Cisplatin	SLIT Cisplatin || SR Inhaled Lipid Cisplatin || Sustained-release Lipid Inhalation Targeting Cisplatin || Sustained-release Lipid Inhaled Cisplatin || Sustained-release Lipid Inhaled Cisplatin	SUSTAINEDRELEASELIPIDINHALEDCISPLATIN	SLITCISPLATIN||SRINHALEDLIPIDCISPLATIN||SUSTAINEDRELEASELIPIDINHALATIONTARGETINGCISPLATIN||SUSTAINEDRELEASELIPIDINHALEDCISPLATIN||SUSTAINEDRELEASELIPIDINHALEDCISPLATIN
Cobimetinib		COBIMETINIB || Cobimetinib || Cobimetinib || Cotellic || GDC-0973 || MEK Inhibitor GDC-0973 || XL518	COBIMETINIB	COBIMETINIB||COBIMETINIB||COBIMETINIB||COTELLIC||GDC0973||MEKINHIBITORGDC0973||XL518
Coenzyme Q10		"2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione || Co-Q10 || CoQ10 || Coenzyme Q10 || Coenzyme Q10 || Coenzyme Q10 || Q10 || UBIDECARENONE || Ubidecarenone || Ubidecarenone || Ubiquinone 10 || coenzyme Q10 || ubiquinone || vitamin Q10"	COENZYMEQ10	"25,6DIMETHOXY3METHYL2,5CYCLOHEXADIENE1,4DIONE||COQ10||COQ10||COENZYMEQ10||COENZYMEQ10||COENZYMEQ10||Q10||UBIDECARENONE||UBIDECARENONE||UBIDECARENONE||UBIQUINONE10||COENZYMEQ10||UBIQUINONE||VITAMINQ10"
Copanlisib		BAY 80-6946 || COPANLISIB || Copanlisib || Copanlisib || PI3K Inhibitor BAY 80-6946	COPANLISIB	BAY806946||COPANLISIB||COPANLISIB||COPANLISIB||PI3KINHIBITORBAY806946
Crenolanib		"4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]- || CP-868,596 || CP-868596 || CRENOLANIB || Crenolanib || PDGFR Inhibitor CP-868596 || [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine"	CRENOLANIB	"4PIPERIDINAMINE,1[2[5[BENZIMIDAZOL1YL]QUINOLIN8YL]PIPERIDIN4YL]AMINE"
Crizotinib		"(R)-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(Piperidin-4-Yl)-1h-Pyrazol-4-Yl)Pyridin-2-Amine || 2-Pyridinamine, 3-((1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(4-Piperidinyl)-1H-Pyrazol-4-yl)- || CRIZOTINIB || Crizotinib || Crizotinib || MET Tyrosine Kinase Inhibitor PF-02341066 || MET tyrosine kinase inhibitor PF-02341066 || PF-02341066 || PF-2341066 || Xalkori"	CRIZOTINIB	||CRIZOTINIB||CRIZOTINIB||CRIZOTINIB||METTYROSINEKINASEINHIBITORPF02341066||METTYROSINEKINASEINHIBITORPF02341066||PF02341066||PF2341066||XALKORI
CSF-1R Inhibitor BLZ945		"4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide || 4-[2((1R,2R)-2-Hydroxycyclohexylamino)-benzothiazol-6-yloxyl]-pyridine- 2-carboxylic Acid Methylamide || BLZ 945 || BLZ-945 || BLZ945 || CSF-1R Inhibitor BLZ945"	CSF1RINHIBITORBLZ945	4BENZOTHIAZOL6YLOXYL]PYRIDINE2CARBOXYLICACIDMETHYLAMIDE||BLZ945||BLZ945||BLZ945||CSF1RINHIBITORBLZ945
Curcumin		"(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione || C.I. 75300 || C.I. Natural Yellow 3 || CURCUMIN || Curcumin || Curcumin || Curcumin || Curcumin || Diferuloylmethane || Turmeric Yellow || curcumin"	CURCUMIN	"1,6HEPTADIENE3,5DIONE||C.I.75300||C.I.NATURALYELLOW3||CURCUMIN||CURCUMIN||CURCUMIN||CURCUMIN||CURCUMIN||DIFERULOYLMETHANE||TURMERICYELLOW||CURCUMIN"
Curcumin	Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110	Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110 || IMX 110 || IMX-110 || IMX110 || Stat3/NF-kB/poly-tyrosine Kinase Inhibitor/Doxorubicin-encapsulating Nanoparticle IMX-110	CURCUMIN/DOXORUBICINENCAPSULATINGNANOPARTICLEIMX110	CURCUMIN/DOXORUBICINENCAPSULATINGNANOPARTICLEIMX110||IMX110||IMX110||IMX110||STAT3/NFKB/POLYTYROSINEKINASEINHIBITOR/DOXORUBICINENCAPSULATINGNANOPARTICLEIMX110
Curcumin	Liposomal Curcumin	Curcumin Liposome || Liposomal Curcumin	LIPOSOMALCURCUMIN	CURCUMINLIPOSOME||LIPOSOMALCURCUMIN
Curcumin	Olive Oil Extract/Curcumin-based Capsule	Olive Oil Extract/Curcumin-based Capsule || PhytoMed Medical Food Suppement	OLIVEOILEXTRACT/CURCUMINBASEDCAPSULE	OLIVEOILEXTRACT/CURCUMINBASEDCAPSULE||PHYTOMEDMEDICALFOODSUPPEMENT
Cytarabine		".beta.-Cytosine arabinoside || 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone || 1-.beta.-D-Arabinofuranosylcytosine || 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone || 1-Beta-D-arabinofuranosylcytosine || 1-Beta-D-arabinofuranosylcytosine || 1.beta.-D-Arabinofuranosylcytosine || 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl- || 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl- || 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone || ARA-cell || Alexan || Ara-C || Arabine || Arabinofuranosylcytosine || Arabinofuranosylcytosine || Arabinosylcytosine || Arabinosylcytosine || Aracytidine || Aracytidine || Aracytin || Aracytine || Beta-Cytosine Arabinoside || Beta-cytosine Arabinoside || CHX-3311 || CYTARABINE || Cytarabine || Cytarabine || Cytarabine || Cytarabinum || Cytarbel || Cytosar || Cytosar || Cytosar-U || Cytosine Arabinoside || Cytosine-.beta.-arabinoside || Cytosine-beta-arabinoside || Erpalfa || Starasid || Tarabine PFS || U 19920 || U 19920 || U-19920 || Udicil || WR-28453 || cytarabine"	CYTARABINE	.BETA.CYTOSINEARABINOSIDE||1.BETA.DARABINOFURANOSYL4AMINO2PYRIMIDINONE||ARACELL||ALEXAN||ARAC||ARABINE||ARABINOFURANOSYLCYTOSINE||ARABINOFURANOSYLCYTOSINE||ARABINOSYLCYTOSINE||ARABINOSYLCYTOSINE||ARACYTIDINE||ARACYTIDINE||ARACYTIN||ARACYTINE||BETACYTOSINEARABINOSIDE||BETACYTOSINEARABINOSIDE||CHX3311||CYTARABINE||CYTARABINE||CYTARABINE||CYTARABINE||CYTARABINUM||CYTARBEL||CYTOSAR||CYTOSAR||CYTOSARU||CYTOSINEARABINOSIDE||CYTOSINE.BETA.ARABINOSIDE||CYTOSINEBETAARABINOSIDE||ERPALFA||STARASID||TARABINEPFS||U19920||U19920||U19920||UDICIL||WR28453||CYTARABINE
Cytarabine	Cytarabine Monophosphate Prodrug MB07133	"(2R,4S)-4-amino-1-[5-O-[2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl]-beta-d-arabinofuranosyl]-2(1H)-pyrimidinone || Cytarabine Monophosphate Prodrug MB07133 || Cytarabine Prodrug MB07133 || MB07133"	CYTARABINEMONOPHOSPHATEPRODRUGMB07133	PYRIMIDINONE||CYTARABINEMONOPHOSPHATEPRODRUGMB07133||CYTARABINEPRODRUGMB07133||MB07133
Dabrafenib		"BRAF Inhibitor GSK2118436 || Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro- || DABRAFENIB || Dabrafenib || Dabrafenib || GSK-2118436 || GSK-2118436A || GSK2118436"	DABRAFENIB	"BRAFINHIBITORGSK2118436||BENZENESULFONAMIDE,N2,6DIFLUORO||DABRAFENIB||DABRAFENIB||DABRAFENIB||GSK2118436||GSK2118436A||GSK2118436"
Dabrafenib	Dabrafenib Mesylate	DABRAFENIB MESYLATE || Dabrafenib Mesylate || Dabrafenib Mesylate || Dabrafenib Methanesulfonate || GSK2118436 Methane Sulfonate Salt || GSK2118436B || Tafinlar	DABRAFENIBMESYLATE	DABRAFENIBMESYLATE||DABRAFENIBMESYLATE||DABRAFENIBMESYLATE||DABRAFENIBMETHANESULFONATE||GSK2118436METHANESULFONATESALT||GSK2118436B||TAFINLAR
Dacomitinib		(2E)-N-(4-((3-Chloro-4-Fluorophenyl)Amino)-7-Methoxyquinazolin-6-yl)-4-Piperidin-1-ylbut-2-Enamide || DACOMITINIB || Dacomitinib || Dacomitinib || EGFR Inhibitor PF-00299804 || PF-00299804 || PF-00299804 || PF-00299804-03 || PF-299804 || Vizimpro	DACOMITINIB	4PIPERIDIN1YLBUT2ENAMIDE||DACOMITINIB||DACOMITINIB||DACOMITINIB||EGFRINHIBITORPF00299804||PF00299804||PF00299804||PF0029980403||PF299804||VIZIMPRO
Dacomitinib	Carbon C-14 Dacomitinib	Carbon C 14 PF-00299804 || Carbon C-14 Dacomitinib || [14C]PF-00299804	CARBONC14DACOMITINIB	CARBONC14PF00299804||CARBONC14DACOMITINIB||[14C]PF00299804
Dactinomycin		"2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3 || ACTINOMYCIN D || Actinomycin A IV || Actinomycin C1 || Actinomycin D || Actinomycin I1 || Actinomycin IV || Actinomycin IV || Actinomycin X 1 || Actinomycin X 1 || Actinomycin-[thr-val-pro-sar-meval] || Cosmegen || Cosmegen || DACT || DACTINOMYCIN || Dactinomycin || Dactinomycin || Dactinomycin || Dactinomycine || Lyovac Cosmegen || Lyovac cosmegen || Meractinomycin || Meractinomycin || dactinomycin"	DACTINOMYCIN	"2BIS[CYCLO]1,9DIMETHYL4,63HPHENOXAZINONE3||ACTINOMYCIND||ACTINOMYCINAIV||ACTINOMYCINC1||ACTINOMYCIND||ACTINOMYCINI1||ACTINOMYCINIV||ACTINOMYCINIV||ACTINOMYCINX1||ACTINOMYCINX1||ACTINOMYCIN[THRVALPROSARMEVAL]||COSMEGEN||COSMEGEN||DACT||DACTINOMYCIN||DACTINOMYCIN||DACTINOMYCIN||DACTINOMYCIN||DACTINOMYCINE||LYOVACCOSMEGEN||LYOVACCOSMEGEN||MERACTINOMYCIN||MERACTINOMYCIN||DACTINOMYCIN"
Dactolisib		"BEZ235 || Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl- || DACTOLISIB || Dactolisib || Dactolisib || NVPBEZ235"	DACTOLISIB	"BEZ235||BENZENEACETONITRILE,4ALPHA,ALPHADIMETHYL||DACTOLISIB||DACTOLISIB||DACTOLISIB||NVPBEZ235"
Dactolisib	Dactolisib Tosylate	"2-Methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile 4-Methylbenzenesulfonate || Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-, 4-Methylbenzenesulfonate (1:1) || DACTOLISIB TOSYLATE || Dactolisib Tosylate || NVP-BEZ235-ANA || NVP-BEZ235-NX"	DACTOLISIBTOSYLATE	2METHYL2||DACTOLISIBTOSYLATE||DACTOLISIBTOSYLATE||NVPBEZ235ANA||NVPBEZ235NX
Daniquidone		"8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one || Batracylin || Bay H 2049 || DANIQUIDONE || Daniquidone || Daniquidone || batracylin"	DANIQUIDONE	8AMINOISOINDOLOONE||BATRACYLIN||BAYH2049||DANIQUIDONE||DANIQUIDONE||DANIQUIDONE||BATRACYLIN
Darolutamide		Antiandrogen ODM-201 || BAY 1841788 || BAY-1841788 || BAY1841788 || DAROLUTAMIDE || Darolutamide || ODM 201 || ODM-201	DAROLUTAMIDE	ANTIANDROGENODM201||BAY1841788||BAY1841788||BAY1841788||DAROLUTAMIDE||DAROLUTAMIDE||ODM201||ODM201
Dasatinib		"5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate || BMS-354825 || BMS-354825 || DASATINIB || Dasatinib || Dasatinib || Dasatinib || Dasatinib Hydrate || Dasatinib Monohydrate || Sprycel || Sprycel || dasatinib"	DASATINIB	"5THIAZOLECARBOXAMIDE,N,MONOHYDRATE||BMS354825||BMS354825||DASATINIB||DASATINIB||DASATINIB||DASATINIB||DASATINIBHYDRATE||DASATINIBMONOHYDRATE||SPRYCEL||SPRYCEL||DASATINIB"
DHA-Paclitaxel		DHA-Paclitaxel || DHA-Paclitaxel || DHA-paclitaxel || Docosahexaenoic Acid-Paclitaxel conjugate || TXP || Taxoprexin	DHAPACLITAXEL	DHAPACLITAXEL||DHAPACLITAXEL||DHAPACLITAXEL||DOCOSAHEXAENOICACIDPACLITAXELCONJUGATE||TXP||TAXOPREXIN
Dihydrolenperone		"1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]- || 1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]- || DIHYDROLENPERONE || Dihydro-lenperone || Dihydro-lenperone || Dihydrolenperone || Dihydrolenperone || RMI 11974"	DIHYDROLENPERONE	"1BUTANONE,1HYDROXYMETHYL]1PIPERIDINYL]||DIHYDROLENPERONE||DIHYDROLENPERONE||DIHYDROLENPERONE||DIHYDROLENPERONE||DIHYDROLENPERONE||RMI11974"
Dinaciclib		"2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5- a]pyrimidin-5-yl]-, (2S)- || CDK Inhibitor SCH 727965 || CDK inhibitor SCH 727965 || DINACICLIB || Dinaciclib || Dinaciclib || MK-7965 || SCH 727965 || dinaciclib"	DINACICLIB	"2PIPERIDINEETHANOL,1[3ETHYL7[[||CDKINHIBITORSCH727965||CDKINHIBITORSCH727965||DINACICLIB||DINACICLIB||DINACICLIB||MK7965||SCH727965||DINACICLIB"
Dovitinib		DOVITINIB || Dovitinib || Dovitinib	DOVITINIB	DOVITINIB||DOVITINIB||DOVITINIB
Dovitinib	Dovitinib Lactate	4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one mono 2-hydroxypropanoate Hydrate || CHIR-258 || DOVITINIB LACTATE || Dovitinib Lactate || Dovitinib Lactate || RTK Inhibitor TKI258 || TKI258	DOVITINIBLACTATE	4AMINO5FLUORO3ONEMONO2HYDROXYPROPANOATEHYDRATE||CHIR258||DOVITINIBLACTATE||DOVITINIBLACTATE||DOVITINIBLACTATE||RTKINHIBITORTKI258||TKI258
Doxorubicin	Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101	2B3-101 || Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101	GLUTATHIONEPEGYLATEDLIPOSOMALDOXORUBICINHYDROCHLORIDEFORMULATION2B3101	2B3101||GLUTATHIONEPEGYLATEDLIPOSOMALDOXORUBICINHYDROCHLORIDEFORMULATION2B3101
Doxorubicin	HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302	HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 || HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 || MM-302	HER2TARGETEDLIPOSOMALDOXORUBICINHYDROCHLORIDEMM302	HER2TARGETEDLIPOSOMALDOXORUBICINHYDROCHLORIDEMM302||HER2TARGETEDLIPOSOMALDOXORUBICINHYDROCHLORIDEMM302||MM302
Doxorubicin	Lyso-Thermosensitive Liposome Doxorubicin	Heat-Activated Liposomal Doxorubicin Hydrochloride || Lyso-Thermosensitive Liposome Doxorubicin || Lyso-Thermosensitive Liposome Doxorubicin || Temperature Sensitive Liposome Encapsulated Doxorubicin || ThermoDox	LYSOTHERMOSENSITIVELIPOSOMEDOXORUBICIN	HEATACTIVATEDLIPOSOMALDOXORUBICINHYDROCHLORIDE||LYSOTHERMOSENSITIVELIPOSOMEDOXORUBICIN||LYSOTHERMOSENSITIVELIPOSOMEDOXORUBICIN||TEMPERATURESENSITIVELIPOSOMEENCAPSULATEDDOXORUBICIN||THERMODOX
Doxorubicin	Pegylated Liposomal Doxorubicin Hydrochloride	"(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride || ATI-0918 || Caelyx || DOX-SL || DOXIL || Dox-SL || Doxil || Doxil || Doxilen || Doxorubicin HCl Liposomal || Doxorubicin HCl Liposome || Doxorubicin Hydrochloride Liposome || Duomeisu || Evacet || Evacet || LipoDox || LipoDox || Lipodox 50 || Liposomal Adriamycin || Liposomal Doxorubicin Hydrochloride || Liposomal-Encapsulated Doxorubicin || Pegylated Doxorubicin HCl Liposome || Pegylated Liposomal Doxorubicin Hydrochloride || Pegylated Liposomal Doxorubicin Hydrochloride || S-Liposomal Doxorubicin || Stealth Liposomal Doxorubicin || TLC D-99 || doxorubicin hydrochloride liposome || liposomal doxorubicin hydrochloride"	PEGYLATEDLIPOSOMALDOXORUBICINHYDROCHLORIDE	"OXY]7,8,9,10TETRAHYDRO6,8,11TRIHYDROXY1METHOXY5,12NAPHTHACENEDIONEHYDROCHLORIDE||ATI0918||CAELYX||DOXSL||DOXIL||DOXSL||DOXIL||DOXIL||DOXILEN||DOXORUBICINHCLLIPOSOMAL||DOXORUBICINHCLLIPOSOME||DOXORUBICINHYDROCHLORIDELIPOSOME||DUOMEISU||EVACET||EVACET||LIPODOX||LIPODOX||LIPODOX50||LIPOSOMALADRIAMYCIN||LIPOSOMALDOXORUBICINHYDROCHLORIDE||LIPOSOMALENCAPSULATEDDOXORUBICIN||PEGYLATEDDOXORUBICINHCLLIPOSOME||PEGYLATEDLIPOSOMALDOXORUBICINHYDROCHLORIDE||PEGYLATEDLIPOSOMALDOXORUBICINHYDROCHLORIDE||SLIPOSOMALDOXORUBICIN||STEALTHLIPOSOMALDOXORUBICIN||TLCD99||DOXORUBICINHYDROCHLORIDELIPOSOME||LIPOSOMALDOXORUBICINHYDROCHLORIDE"
DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555		DTRM 555 || DTRM-555 || DTRM555 || DTRMWXHS-12-Everolimus-Pomalidomide || DTRMWXHS-12/Everolimus/Pomalidomide || DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 || DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555	DTRMWXHS12/EVEROLIMUS/POMALIDOMIDECOMBINATIONAGENTDTRM555	DTRM555||DTRM555||DTRM555||DTRMWXHS12EVEROLIMUSPOMALIDOMIDE||DTRMWXHS12/EVEROLIMUS/POMALIDOMIDE||DTRMWXHS12/EVEROLIMUS/POMALIDOMIDECOMBINATIONAGENTDTRM555||DTRMWXHS12/EVEROLIMUS/POMALIDOMIDECOMBINATIONAGENTDTRM555
Dual IGF-1R/InsR Inhibitor BMS-754807		BMS-754807 || BMS-754807 || Dual IGF-1R/InsR Inhibitor BMS-754807 || Dual IGF-1R/InsR Inhibitor BMS-754807	DUALIGF1R/INSRINHIBITORBMS754807	BMS754807||BMS754807||DUALIGF1R/INSRINHIBITORBMS754807||DUALIGF1R/INSRINHIBITORBMS754807
Dubermatinib		"2-((5-Chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide || DUBERMATINIB || Dubermatinib || Dubermatinib || TP 0903 || TP-0903 || TP0903"	DUBERMATINIB	"2N,NDIMETHYLBENZENESULFONAMIDE||DUBERMATINIB||DUBERMATINIB||DUBERMATINIB||TP0903||TP0903||TP0903"
Durvalumab		"DURVALUMAB || Durvalumab || Durvalumab || Imfinzi || Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer || MEDI-4736 || MEDI4736"	DURVALUMAB	"DURVALUMAB||DURVALUMAB||DURVALUMAB||IMFINZI||IMMUNOGLOBULING1,ANTI,DISULFIDEWITHHUMANMONOCLONALMEDI4736KAPPACHAIN,DIMER||MEDI4736||MEDI4736"
Elesclomol		"1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazidide || ELESCLOMOL || Elesclomol || Elesclomol || Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]"	ELESCLOMOL	1N'BENZENECARBOTHIOYL3HYDRAZIDE]
Elesclomol	Elesclomol Sodium	"1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazidide Sodium || ELESCLOMOL SODIUM || Elesclomol Sodium || Elesclomol Sodium || Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide], Sodium Salt || STA-4783 || elesclomol sodium"	ELESCLOMOLSODIUM	"1N'BENZENECARBOTHIOYL3HYDRAZIDE],SODIUMSALT||STA4783||ELESCLOMOLSODIUM"
Entospletinib		"6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine || ENTO || ENTOSPLETINIB || Entospletinib || Entospletinib || GS 9973 || GS-9973 || Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-"	ENTOSPLETINIB	6
Entrectinib		"ENTRECTINIB || Entrectinib || N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide || RXDX 101 || RXDX-101 || RXDX101 || Rozlytrek"	ENTRECTINIB	ENTRECTINIB||ENTRECTINIB||NBENZAMIDE||RXDX101||RXDX101||RXDX101||ROZLYTREK
Enzalutamide		"ASP9785 || Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl- || ENZALUTAMIDE || Enzalutamide || Enzalutamide || MDV3100 || Xtandi"	ENZALUTAMIDE	"ASP9785||BENZAMIDE,42FLUORONMETHYL||ENZALUTAMIDE||ENZALUTAMIDE||ENZALUTAMIDE||MDV3100||XTANDI"
Enzalutamide	Deuterated Enzalutamide	D3-ENT || Deuterated Enzalutamide || Deuterated Enzalutamide || Enzalutamide Deuterated || HC 1119 || HC-1119 || HC1119 || N-trideuteromethyl Enzalutamide	DEUTERATEDENZALUTAMIDE	D3ENT||DEUTERATEDENZALUTAMIDE||DEUTERATEDENZALUTAMIDE||ENZALUTAMIDEDEUTERATED||HC1119||HC1119||HC1119||NTRIDEUTEROMETHYLENZALUTAMIDE
Erdafitinib		"1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)- || Balversa || ERDAFITINIB || Erdafitinib || Erdafitinib || JNJ-42756493"	ERDAFITINIB	"1,2ETHANEDIAMINE,N1||BALVERSA||ERDAFITINIB||ERDAFITINIB||ERDAFITINIB||JNJ42756493"
Eribulin		"2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one || ER-086526 || ERIBULIN || Eribulin"	ERIBULIN	2ONE||ER086526||ERIBULIN||ERIBULIN
Eribulin	Carbon C 14 Eribulin Acetate	14C-Eribulin Acetate || Carbon C 14 Eribulin Acetate	CARBONC14ERIBULINACETATE	14CERIBULINACETATE||CARBONC14ERIBULINACETATE
Eribulin	Eribulin Mesylate	"2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one || B1939 Mesylate || E7389 || E7389 || ER-086526 || ERIBULIN MESYLATE || Eribulin Mesylate || Eribulin Mesylate || Halaven || Halaven || Halichondrin B Analog || eribulin mesylate"	ERIBULINMESYLATE	2ONE||B1939MESYLATE||E7389||E7389||ER086526||ERIBULINMESYLATE||ERIBULINMESYLATE||ERIBULINMESYLATE||HALAVEN||HALAVEN||HALICHONDRINBANALOG||ERIBULINMESYLATE
Eribulin	Liposomal Eribulin Mesylate	E7389 Liposomal Formulation || E7389-LF || Liposomal Eribulin Mesylate	LIPOSOMALERIBULINMESYLATE	E7389LIPOSOMALFORMULATION||E7389LF||LIPOSOMALERIBULINMESYLATE
Erlotinib		ERLOTINIB || Erlotinib || Erlotinib || erlotinib	ERLOTINIB	ERLOTINIB||ERLOTINIB||ERLOTINIB||ERLOTINIB
Erlotinib	Erlotinib Hydrochloride	"CP-358,774 || Cp-358,774 || ERLOTINIB HYDROCHLORIDE || Erlotinib Hydrochloride || Erlotinib Hydrochloride || Erlotinib Hydrochloride || Erlotinib Hydrochloride || N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride || OSI-774 || OSI-774 || Tarceva || Tarceva || erlotinib hydrochloride"	ERLOTINIBHYDROCHLORIDE	"CP358,774||CP358,774||ERLOTINIBHYDROCHLORIDE||ERLOTINIBHYDROCHLORIDE||ERLOTINIBHYDROCHLORIDE||ERLOTINIBHYDROCHLORIDE||ERLOTINIBHYDROCHLORIDE||N4QUINAZOLINAMINEMONOHYDROCHLORIDE||OSI774||OSI774||TARCEVA||TARCEVA||ERLOTINIBHYDROCHLORIDE"
Ethinylestradiol	Ethinyl Estradiol	"(17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol || (17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol || Diogyn E || Diogyn E || Diogyn-E || ETHINYL ESTRADIOL || Estinyl || Estinyl || Ethinoral || Ethinoral || Ethinyl Estradiol || Ethinyl Estradiol || Ethinylestradiol || Ethinylestradiol || Eticylol || Eticylol || Feminone || Feminone || Inestra || Inestra || Lynoral || Lynoral || Orestralyn || Orestralyn"	ETHINYLESTRADIOL	"TRIEN20YNE3,17DIOL||DIOGYNE||DIOGYNE||DIOGYNE||ETHINYLESTRADIOL||ESTINYL||ESTINYL||ETHINORAL||ETHINORAL||ETHINYLESTRADIOL||ETHINYLESTRADIOL||ETHINYLESTRADIOL||ETHINYLESTRADIOL||ETICYLOL||ETICYLOL||FEMINONE||FEMINONE||INESTRA||INESTRA||LYNORAL||LYNORAL||ORESTRALYN||ORESTRALYN"
Etirinotecan Pegol		ETIRINOTECAN PEGOL || Etirinotecan Pegol || Etirinotecan Pegol || NKTR 102 || NKTR-102 || Onzeald || PEG-Irinotecan	ETIRINOTECANPEGOL	ETIRINOTECANPEGOL||ETIRINOTECANPEGOL||ETIRINOTECANPEGOL||NKTR102||NKTR102||ONZEALD||PEGIRINOTECAN
Everolimus		"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone || 42-O-(2-Hydroxy)ethyl Rapamycin || Afinitor || Afinitor || Certican || EVEROLIMUS || Everolimus || Everolimus || Everolimus || RAD 001 || RAD001 || RAD001 || Votubia || Zortress || everolimus"	EVEROLIMUS	ETHYLRAPAMYCIN||AFINITOR||AFINITOR||CERTICAN||EVEROLIMUS||EVEROLIMUS||EVEROLIMUS||EVEROLIMUS||RAD001||RAD001||RAD001||VOTUBIA||ZORTRESS||EVEROLIMUS
Everolimus	Everolimus Tablets for Oral Suspension	Afinitor Disperz || Everolimus Tablets for Oral Suspension	EVEROLIMUSTABLETSFORORALSUSPENSION	AFINITORDISPERZ||EVEROLIMUSTABLETSFORORALSUSPENSION
Exemestane		"6-Methyleneandrosta-1,4-diene-3,17-dione || Aromasin || Aromasin || EXEMESTANE || Exemestane || Exemestane || Exemestane || Exemestane || FCE-24304 || exemestane"	EXEMESTANE	"6METHYLENEANDROSTA1,4DIENE3,17DIONE||AROMASIN||AROMASIN||EXEMESTANE||EXEMESTANE||EXEMESTANE||EXEMESTANE||EXEMESTANE||FCE24304||EXEMESTANE"
Exicorilant		"CORT 125281 || CORT-1252 || CORT125281 || EXICORILANT || Exicorilant || Exicorilant || Glucocorticoid Receptor Antagonist CORT125281 || Methanone, ((4aR,8aS)-1-(4-Fluorophenyl)-1,4,5,6,7,8,8a,9-octahydro-6-((2-methyl-2H-1,2,3-triazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)- || WHO 10854"	EXICORILANT	"CORT125281||CORT1252||CORT125281||EXICORILANT||EXICORILANT||EXICORILANT||GLUCOCORTICOIDRECEPTORANTAGONISTCORT125281||METHANONE,||WHO10854"
Fedratinib		"Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)- || FEDRATINIB || Fedratinib || Fedratinib || SAR302503 || TG101348"	FEDRATINIB	"BENZENESULFONAMIDE,N||FEDRATINIB||FEDRATINIB||FEDRATINIB||SAR302503||TG101348"
FGFR Inhibitor AZD4547		AZD4547 || FGFR Inhibitor AZD4547 || FGFR Inhibitor AZD4547	FGFRINHIBITORAZD4547	AZD4547||FGFRINHIBITORAZD4547||FGFRINHIBITORAZD4547
FLT3/ABL/Aurora Kinase Inhibitor KW-2449		FLT3/ABL/Aurora Kinase Inhibitor KW-2449 || FLT3/ABL/Aurora Kinase Inhibitor KW-2449 || KW-2449	FLT3/ABL/AURORAKINASEINHIBITORKW2449	FLT3/ABL/AURORAKINASEINHIBITORKW2449||FLT3/ABL/AURORAKINASEINHIBITORKW2449||KW2449
Fluzoparib		"4-((3-((5,6-Dihydro-2-(trifluoromethyl)(1,2,4)triazolo(1,5-a)pyrazin-7(8H)-yl)carbonyl)-4-fluorophenyl)methyl)-1(2H)-phthalazinone || FLUZOPARIB || Fluzoparib || SHR-3162 || SHR3162"	FLUZOPARIB	4PHTHALAZINONE||FLUZOPARIB||FLUZOPARIB||SHR3162||SHR3162
Foretinib		"FORETINIB || Foretinib || Foretinib || GSK1363089 || MET/VEGFR-2 inhibitor GSK1363089 || Multitargeted Tyrosine Kinase Inhibitor GSK1363089 || N-(3-Fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide || XL880 || XL880 || foretinib"	FORETINIB	"FORETINIB||FORETINIB||FORETINIB||GSK1363089||MET/VEGFR2INHIBITORGSK1363089||MULTITARGETEDTYROSINEKINASEINHIBITORGSK1363089||NCYCLOPROPANE1,1DICARBOXAMIDE||XL880||XL880||FORETINIB"
Fosgemcitabine Palabenamide	Fosgemcitabine Palabenamide	Acelarin || FOSGEMCITABINE PALABENAMIDE || Fosgemcitabine Palabenamide || Fosgemcitabine Palabenamide || Gemictabine ProTide || NUC 1031 || NUC-1031	FOSGEMCITABINEPALABENAMIDE	ACELARIN||FOSGEMCITABINEPALABENAMIDE||FOSGEMCITABINEPALABENAMIDE||FOSGEMCITABINEPALABENAMIDE||GEMICTABINEPROTIDE||NUC1031||NUC1031
Fulvestrant		"7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol || FULVESTRANT || Faslodex || Faslodex || Faslodex(ICI 182,780) || Fulvestrant || Fulvestrant || Fulvestrant || ICI 182,780 || ICI 182780 || ZD9238 || fulvestrant"	FULVESTRANT	"7A[9[||FULVESTRANT||FULVESTRANT||FULVESTRANT||ICI182,780||ICI182780||ZD9238||FULVESTRANT"
Gefitinib		4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline || GEFITINIB || Gefitinib || Gefitinib || Gefitinib || Iressa || Iressa || Iressa || N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) propoxy]-4-quinazolinamine || ZD 1839 || ZD 1839 || ZD1839 || gefitinib	GEFITINIB	4PROPOXY]4QUINAZOLINAMINE||ZD1839||ZD1839||ZD1839||GEFITINIB
Gemcitabine	Aerosol Gemcitabine	Aerosol Gemcitabine || Aerosol Gemcitabine || Aerosolized GCB || Aerosolized Gemcitabine	AEROSOLGEMCITABINE	AEROSOLGEMCITABINE||AEROSOLGEMCITABINE||AEROSOLIZEDGCB||AEROSOLIZEDGEMCITABINE
Gemcitabine	Gemcitabine Elaidate	CP-4126 || GEMCITABINE ELAIDATE || Gemcitabine 5'-Elaidic Acid Ester || Gemcitabine Elaidate || Gemcitabine Elaidate	GEMCITABINEELAIDATE	CP4126||GEMCITABINEELAIDATE||GEMCITABINE5'ELAIDICACIDESTER||GEMCITABINEELAIDATE||GEMCITABINEELAIDATE
Gemcitabine	Gemcitabine Hydrochloride	"1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, hydrochloride || 2'Deoxy-2',2'-Difluorocytidine, Hydrochloride || Difluorodeoxycytidine Hydrochloride || FF 10832 || FF-10832 || FF10832 || GEMCITABINE HYDROCHLORIDE || Gemcitabine HCI || Gemcitabine Hydrochloride || Gemcitabine Hydrochloride || Gemzar || Gemzar || LY-188011 || LY188011 || dFdCyd || gemcitabine hydrochloride"	GEMCITABINEHYDROCHLORIDE	"12DEOXY2,2DIFLUORORIBOSE,HYDROCHLORIDE||2'DEOXY2',2'DIFLUOROCYTIDINE,HYDROCHLORIDE||DIFLUORODEOXYCYTIDINEHYDROCHLORIDE||FF10832||FF10832||FF10832||GEMCITABINEHYDROCHLORIDE||GEMCITABINEHCI||GEMCITABINEHYDROCHLORIDE||GEMCITABINEHYDROCHLORIDE||GEMZAR||GEMZAR||LY188011||LY188011||DFDCYD||GEMCITABINEHYDROCHLORIDE"
Gemcitabine	Gemcitabine Hydrochloride Emulsion	D07001-F4 || Gemcitabine Hydrochloride Emulsion	GEMCITABINEHYDROCHLORIDEEMULSION	D07001F4||GEMCITABINEHYDROCHLORIDEEMULSION
Gemcitabine	Gemcitabine Prodrug LY2334737	Gemcitabine Prodrug LY2334737 || Gemcitabine Prodrug LY2334737 || LY2334737	GEMCITABINEPRODRUGLY2334737	GEMCITABINEPRODRUGLY2334737||GEMCITABINEPRODRUGLY2334737||LY2334737
Gemcitabine	Gemcitabine-Releasing Intravesical System	GemRIS || Gemcitabine-Releasing Intravesical System || Gemcitabine-Releasing Intravesical System || TAR 200 || TAR-200	GEMCITABINERELEASINGINTRAVESICALSYSTEM	GEMRIS||GEMCITABINERELEASINGINTRAVESICALSYSTEM||GEMCITABINERELEASINGINTRAVESICALSYSTEM||TAR200||TAR200
Gemcitabine	Topical Gemcitabine Hydrochloride	Topical Gemcitabine Hydrochloride	TOPICALGEMCITABINEHYDROCHLORIDE	TOPICALGEMCITABINEHYDROCHLORIDE
Genistein		"4',5, 7-Trihydroxyisoflavone || 4',5,7-Trihydroxyisoflavone || 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one || GENISTEIN || Genestein || Genistein || Genistein || Genistein || Genistein || Genistein || Genisteol || Genisteol || Prunetol || Prunetol || genistein"	GENISTEIN	"4',5,7TRIHYDROXYISOFLAVONE||4',5,7TRIHYDROXYISOFLAVONE||5,7DIHYDROXY34H1BENZOPYRAN4ONE||GENISTEIN||GENESTEIN||GENISTEIN||GENISTEIN||GENISTEIN||GENISTEIN||GENISTEIN||GENISTEOL||GENISTEOL||PRUNETOL||PRUNETOL||GENISTEIN"
Genistein	Crystalline Genistein Formulation AXP107-11	AXP107-11 || Crystalline Genistein Formulation AXP107-11	CRYSTALLINEGENISTEINFORMULATIONAXP10711	AXP10711||CRYSTALLINEGENISTEINFORMULATIONAXP10711
Gilteritinib		6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide || ASP-2215 || ASP2215 || GILTERITINIB || Gilteritinib || Gilteritinib || Gilteritinib	GILTERITINIB	6ETHYL3PYRAZINE2CARBOXAMIDE||ASP2215||ASP2215||GILTERITINIB||GILTERITINIB||GILTERITINIB||GILTERITINIB
Gilteritinib Fumarate		"2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-, (2E)-2-Butenedioate (2:1) || ASP-2215 Hemifumarate || ASP2215 Hemifumarate || GILTERITINIB FUMARATE || Gilteritinib Fumarate || Gilteritinib Fumarate || Gilteritinib Hemifumarate || Xospata"	GILTERITINIBFUMARATE	"2PYRAZINECARBOXAMIDE,6ETHYL3||ASP2215HEMIFUMARATE||ASP2215HEMIFUMARATE||GILTERITINIBFUMARATE||GILTERITINIBFUMARATE||GILTERITINIBFUMARATE||GILTERITINIBHEMIFUMARATE||XOSPATA"
GITRL RNA-transfected Autologous Dendritic Cell Vaccine		GITRL RNA DC || GITRL RNA-transfected Autologous DC || GITRL RNA-transfected Autologous Dendritic Cell Vaccine || GITRL RNA-transfected Autologous Dendritic Cell Vaccine	GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE	GITRLRNADC||GITRLRNATRANSFECTEDAUTOLOGOUSDC||GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE||GITRLRNATRANSFECTEDAUTOLOGOUSDENDRITICCELLVACCINE
Glesatinib		GLESATINIB || Glesatinib || Glesatinib || MG90265 || MG90265X || MGCD265 || TKI MGCD265	GLESATINIB	GLESATINIB||GLESATINIB||GLESATINIB||MG90265||MG90265X||MGCD265||TKIMGCD265
Halofuginone		HALOFUGINONE || Halofuginone || Halofuginone || trans-(+/-)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone	HALOFUGINONE	HALOFUGINONE||HALOFUGINONE||HALOFUGINONE||TRANSQUINAZOLINONE
Halofuginone	Halofuginone Hydrobromide	HALOFUGINONE HYDROBROMIDE || Halofuginone Hydrobromide || Halofuginone Hydrobromide || Halofuginone Hydrobromide || Halofuginone IV (intravenous) || Halofuginone hydrobromide || RU 19110 || Tempostatin || halofuginone hydrobromide	HALOFUGINONEHYDROBROMIDE	HALOFUGINONEHYDROBROMIDE||HALOFUGINONEHYDROBROMIDE||HALOFUGINONEHYDROBROMIDE||HALOFUGINONEHYDROBROMIDE||HALOFUGINONEIV||HALOFUGINONEHYDROBROMIDE||RU19110||TEMPOSTATIN||HALOFUGINONEHYDROBROMIDE
hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine		hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine	HTERT/SURVIVIN/MELANOMATUMORCELLDERIVEDMRNATRANSFECTEDDENDRITICCELLVACCINE	HTERT/SURVIVIN/MELANOMATUMORCELLDERIVEDMRNATRANSFECTEDDENDRITICCELLVACCINE
Ibrutinib		"2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)- || BTK Inhibitor PCI-32765 || CRA-032765 || IBRUTINIB || Ibrutinib || Ibrutinib || Imbruvica || PCI-32765"	IBRUTINIB	"2PROPEN1ONE,1||BTKINHIBITORPCI32765||CRA032765||IBRUTINIB||IBRUTINIB||IBRUTINIB||IMBRUVICA||PCI32765"
Idelalisib		5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H- quinazolin-4-one || CAL-101 || GS 1101 || GS-1101 || IDELALISIB || Idelalisib || Idelalisib || Phosphoinositide-3 Kinase Delta Inhibitor CAL-101 || Zydelig	IDELALISIB	5FLUORO3PHENYL23HQUINAZOLIN4ONE||CAL101||GS1101||GS1101||IDELALISIB||IDELALISIB||IDELALISIB||PHOSPHOINOSITIDE3KINASEDELTAINHIBITORCAL101||ZYDELIG
IGF-methotrexate	IGF-methotrexate 	765IGF-MTX || IGF-methotrexate Conjugate || IGF-methotrexate Conjugate || IGF/MTX || IGF/MTX Conjugate	IGFMETHOTREXATECONJUGATE	765IGFMTX||IGFMETHOTREXATECONJUGATE||IGFMETHOTREXATECONJUGATE||IGF/MTX||IGF/MTXCONJUGATE
Imatinib		4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide || IMATINIB || Imatinib || Imatinib	IMATINIB	4[2PYRIMIDINYL]AMINO]PHENYL]BENZAMIDE||IMATINIB||IMATINIB||IMATINIB
Imatinib	Imatinib Mesylate	4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate || CGP 57148 || CGP57148B || Gleevec || Gleevec || Gleevec || Glivec || IMATINIB MESYLATE || Imatinib Mesylate || Imatinib Mesylate || Imatinib Mesylate || STI 571 || STI-571 || STI571 || STI571 || imatinib mesylate	IMATINIBMESYLATE	4[2PYRIMIDINYL]AMINO]PHENYL]BENZAMIDEMONOMETHANESULFONATE||CGP57148||CGP57148B||GLEEVEC||GLEEVEC||GLEEVEC||GLIVEC||IMATINIBMESYLATE||IMATINIBMESYLATE||IMATINIBMESYLATE||IMATINIBMESYLATE||STI571||STI571||STI571||STI571||IMATINIBMESYLATE
Indisulam		"E7070 || E7070 || INDISULAM || Indisulam || Indisulam || N-(3-Chloro-7-indoyl)-1,4-Benzenedisulfonamide"	INDISULAM	"E7070||E7070||INDISULAM||INDISULAM||INDISULAM||N1,4BENZENEDISULFONAMIDE"
Infigratinib		"3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea || BGJ-398 || BGJ398 || INFIGRATINIB || Infigratinib || Infigratinib"	INFIGRATINIB	31METHYLUREA||BGJ398||BGJ398||INFIGRATINIB||INFIGRATINIB||INFIGRATINIB
Infigratinib	Infigratinib Mesylate	BGJ 398 Mesylate || BGJ-398 Mesylate || INFIGRATINIB MESYLATE || Infigratinib Mesylate	INFIGRATINIBMESYLATE	BGJ398MESYLATE||BGJ398MESYLATE||INFIGRATINIBMESYLATE||INFIGRATINIBMESYLATE
Iobenguane I-131	Cold Contaminant-free Iobenguane I-131	Azedra || Cold Contaminant-free I 131-MIBG || Cold Contaminant-free Iobenguane I 131 || Cold Contaminant-free Iobenguane I-131 || Cold Contaminant-free Iobenguane I-131 || Ultratrace Iodine I 131 Metaiodobenzylguanidine || Ultratrace MIBG	COLDCONTAMINANTFREEIOBENGUANEI131	AZEDRA||COLDCONTAMINANTFREEI131MIBG||COLDCONTAMINANTFREEIOBENGUANEI131||COLDCONTAMINANTFREEIOBENGUANEI131||COLDCONTAMINANTFREEIOBENGUANEI131||ULTRATRACEIODINEI131METAIODOBENZYLGUANIDINE||ULTRATRACEMIBG
Ipilimumab		Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody || BMS-734016 || IPILIMUMAB || Ipilimumab || Ipilimumab || MDX-010 || MDX-010 || MDX-CTLA4 || Yervoy || ipilimumab	IPILIMUMAB	ANTICYTOTOXICTLYMPHOCYTEASSOCIATEDANTIGEN4MONOCLONALANTIBODY||BMS734016||IPILIMUMAB||IPILIMUMAB||IPILIMUMAB||MDX010||MDX010||MDXCTLA4||YERVOY||IPILIMUMAB
Irinotecan		"(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione || (+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate || 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin || IRINOTECAN || Irinotecan || Irinotecan || Irinotecan || [1,4'-bipiperidine]-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester || irinotecan"	IRINOTECAN	"4,11DIETHYL3,4,12,14TETRAHYDRO4HYDROXY3,14DIOXO1HPYRANO[3',4':6,7]INDOLIZINO[1,2B]QUINOLIN9YLESTER||IRINOTECAN"
Irinotecan	Irinotecan Hydrochloride	CPT 11 || CPT 11 || CPT-11 || Campto || Camptosar || Camptosar || Camptosar || Camptothecin 11 || Camptothecin-11 || IRINOTECAN HYDROCHLORIDE || Irinomedac || Irinotecan Hydrochloride || Irinotecan Hydrochloride || Irinotecan Hydrochloride Trihydrate || Irinotecan Monohydrochloride Trihydrate || U-101440E || irinotecan hydrochloride	IRINOTECANHYDROCHLORIDE	CPT11||CPT11||CPT11||CAMPTO||CAMPTOSAR||CAMPTOSAR||CAMPTOSAR||CAMPTOTHECIN11||CAMPTOTHECIN11||IRINOTECANHYDROCHLORIDE||IRINOMEDAC||IRINOTECANHYDROCHLORIDE||IRINOTECANHYDROCHLORIDE||IRINOTECANHYDROCHLORIDETRIHYDRATE||IRINOTECANMONOHYDROCHLORIDETRIHYDRATE||U101440E||IRINOTECANHYDROCHLORIDE
Irinotecan	Irinotecan Sucrosofate	IRINOTECAN SUCROSOFATE || Irinotecan Liposome || Irinotecan Sucrosofate || Irinotecan Sucrosofate || MM-398 || Nanoliposomal Irinotecan || Nanoparticle Liposome Formulation of Irinotecan || Onivyde || PEP02 || nal-IRI	IRINOTECANSUCROSOFATE	IRINOTECANSUCROSOFATE||IRINOTECANLIPOSOME||IRINOTECANSUCROSOFATE||IRINOTECANSUCROSOFATE||MM398||NANOLIPOSOMALIRINOTECAN||NANOPARTICLELIPOSOMEFORMULATIONOFIRINOTECAN||ONIVYDE||PEP02||NALIRI
Irinotecan	Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet	Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet || Oratecan	IRINOTECAN/PGLYCOPROTEININHIBITORHM30181AKCOMBINATIONTABLET	IRINOTECAN/PGLYCOPROTEININHIBITORHM30181AKCOMBINATIONTABLET||ORATECAN
Irinotecan	Pegylated Liposomal Irinotecan	IHL-305 || Pegylated Liposomal Irinotecan || Pegylated Liposomal Irinotecan	PEGYLATEDLIPOSOMALIRINOTECAN	IHL305||PEGYLATEDLIPOSOMALIRINOTECAN||PEGYLATEDLIPOSOMALIRINOTECAN
Irinotecan-	Irinotecan-Eluting Beads	CM-BC2 || Irinotecan Hydrochloride Drug-eluting Beads || Irinotecan-Eluting Beads || Irinotecan-Eluting Beads	IRINOTECANELUTINGBEADS	CMBC2||IRINOTECANHYDROCHLORIDEDRUGELUTINGBEADS||IRINOTECANELUTINGBEADS||IRINOTECANELUTINGBEADS
Isocoumarin NM-3		Isocoumarin NM-3 || NM-3	ISOCOUMARINNM3	ISOCOUMARINNM3||NM3
Ixabepilone		"(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione || (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione || Azaepothilone B || BMS 247550 || BMS-247550 || BMS-247550 || BMS247550 || Epothilone || Epothilone-B BMS 247550 || IXABEPILONE || Ixabepilone || Ixabepilone || Ixempra || Ixempra || ixabepilone"	IXABEPILONE	"ETHENYL]17OXA4AZABICYCLO[14.1.0]HEPTADECANE5,9DIONE||AZAEPOTHILONEB||BMS247550||BMS247550||BMS247550||BMS247550||EPOTHILONE||EPOTHILONEBBMS247550||IXABEPILONE||IXABEPILONE||IXABEPILONE||IXEMPRA||IXEMPRA||IXABEPILONE"
Ixabepilone	Oral Ixabepilone	Oral Ixabepilone	ORALIXABEPILONE	ORALIXABEPILONE
JAK Inhibitor INCB047986		INCB 047986 || INCB-047986 || INCB047986 || JAK Inhibitor INCB047986	JAKINHIBITORINCB047986	INCB047986||INCB047986||INCB047986||JAKINHIBITORINCB047986
JAK2 Inhibitor AZD1480		AZD1480 || JAK2 Inhibitor AZD1480 || JAK2 Inhibitor AZD1480	JAK2INHIBITORAZD1480	AZD1480||JAK2INHIBITORAZD1480||JAK2INHIBITORAZD1480
Kunecatechins	Kunecatechins Ointment	Defined Green Tea Catechin Extract OIntment || Kunecatechins Ointment || Polyphenon E Ointment || Polyphenon E Topical Ointment || Veregen	KUNECATECHINSOINTMENT	DEFINEDGREENTEACATECHINEXTRACTOINTMENT||KUNECATECHINSOINTMENT||POLYPHENONEOINTMENT||POLYPHENONETOPICALOINTMENT||VEREGEN
Lapatinib		GSK572016 || GW 2016 || GW2016 || GW572016 || GW572016 || LAPATINIB || Lapatinib || lapatinib	LAPATINIB	GSK572016||GW2016||GW2016||GW572016||GW572016||LAPATINIB||LAPATINIB||LAPATINIB
Lapatinib	Lapatinib Ditosylate	"4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl), bis(4-methylbenzenesulfonate), Monohydrate || LAPATINIB DITOSYLATE || Lapatinib Ditosylate || Lapatinib Ditosylate || Lapatinib Ditosylate || Tykerb || Tykerb || lapatinib ditosylate"	LAPATINIBDITOSYLATE	"4QUINAZOLINAMINE,N,MONOHYDRATE||LAPATINIBDITOSYLATE||LAPATINIBDITOSYLATE||LAPATINIBDITOSYLATE||LAPATINIBDITOSYLATE||TYKERB||TYKERB||LAPATINIBDITOSYLATE"
Larotrectinib		"1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)- || 3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide || ARRY 470 || LAROTRECTINIB || LOXO 101 || LOXO-101 || Larotrectinib"	LAROTRECTINIB	"1PYRROLIDINECARBOXAMIDE,N3HYDROXYPYRROLIDINE1CARBOXAMIDE||ARRY470||LAROTRECTINIB||LOXO101||LOXO101||LAROTRECTINIB"
Lenalidomide		"3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione || CC-5013 || CC-5013 || CC5013 || CDC 501 || LENALIDOMIDE || Lenalidomide || Lenalidomide || Revlimid || Revlimid || lenalidomide"	LENALIDOMIDE	"3PIPERIDINE2,6DIONE||CC5013||CC5013||CC5013||CDC501||LENALIDOMIDE||LENALIDOMIDE||LENALIDOMIDE||REVLIMID||REVLIMID||LENALIDOMIDE"
Lenalidomide	Lenalidomide Analog KPG-121	KPG 121 || KPG-121 || KPG121 || Lenalidomide Analog KPG-121	LENALIDOMIDEANALOGKPG121	KPG121||KPG121||KPG121||LENALIDOMIDEANALOGKPG121
Lenvatinib		"6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy- || E7080 || ER-203492-00 || LENVATINIB || Lenvatinib || Lenvatinib || Multi-Kinase Inhibitor E7080"	LENVATINIB	"6QUINOLINECARBOXAMIDE,4[3CHLORO4[[CARBONYL]AMINO]PHENOXY]7METHOXY||E7080||ER20349200||LENVATINIB||LENVATINIB||LENVATINIB||MULTIKINASEINHIBITORE7080"
Lenvatinib	Lenvatinib Mesylate	"4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]7-methoxyquinoline-6-carboxamide Mesylate || 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-, methanesulfonate (1:1) || E7080 || LENVATINIB MESYLATE || Lenvatinib Mesylate || Lenvatinib Mesylate || Lenvima || Multi-Kinase Inhibitor E7080"	LENVATINIBMESYLATE	4[3CHLORO4||E7080||LENVATINIBMESYLATE||LENVATINIBMESYLATE||LENVATINIBMESYLATE||LENVIMA||MULTIKINASEINHIBITORE7080
Lestaurtinib		"9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)- || CEP-701 || CEP-701 || CEP-701 || KT-5555 || LESTAURTINIB || Lestaurtinib || Lestaurtinib || SPM-924 || lestaurtinib"	LESTAURTINIB	"9,12EPOXY1HDIINDOLO||CEP701||CEP701||CEP701||KT5555||LESTAURTINIB||LESTAURTINIB||LESTAURTINIB||SPM924||LESTAURTINIB"
Letrozole		"4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile || CGS 20267 || Femara || Femara || Femara || LETROZOLE || Letrozole || Letrozole || Letrozole || Letrozole || letrozole"	LETROZOLE	"4,4'DIBENZONITRILE||CGS20267||FEMARA||FEMARA||FEMARA||LETROZOLE||LETROZOLE||LETROZOLE||LETROZOLE||LETROZOLE||LETROZOLE"
Linifanib		ABT-869 || ABT-869 || LINIFANIB || Linifanib || Linifanib || multitargeted receptor tyrosine kinase inhibitor ABT-869	LINIFANIB	ABT869||ABT869||LINIFANIB||LINIFANIB||LINIFANIB||MULTITARGETEDRECEPTORTYROSINEKINASEINHIBITORABT869
Linoleyl Carbonate-Paclitaxel		2-Linoleyl Carbonate-paclitaxel || LOC-paclitaxel || Linoleyl Carbonate-Paclitaxel || Linoleyl Carbonate-paclitaxel	LINOLEYLCARBONATEPACLITAXEL	2LINOLEYLCARBONATEPACLITAXEL||LOCPACLITAXEL||LINOLEYLCARBONATEPACLITAXEL||LINOLEYLCARBONATEPACLITAXEL
Lorlatinib		"2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)- || 7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile || LORLATINIB || Lorbrena || Lorlatinib || Lorlatinib || PF-06463922"	LORLATINIB	"2H4,8METHENOPYRAZOLOBENZOXADIAZACYCLOTETRADECINE3CARBONITRILE||LORLATINIB||LORBRENA||LORLATINIB||LORLATINIB||PF06463922"
Lovastatin		"(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester || LOVASTATIN || Lovastatin || Lovastatin || Lovastatin || Lovastatin || Lovastatin Sodium || Mevacor || Mevacor || Mevacor || Mevinolin || Monacolin K || lovastatin"	LOVASTATIN	TETRAHYDRO4HYDROXY6OXO2HPYRAN2YL]ETHYL]1NAPHTHALENYLESTER||LOVASTATIN||LOVASTATIN||LOVASTATIN||LOVASTATIN||LOVASTATIN||LOVASTATINSODIUM||MEVACOR||MEVACOR||MEVACOR||MEVINOLIN||MONACOLINK||LOVASTATIN
LSD1 Inhibitor GSK2879552		GSK2879552 || LSD1 Inhibitor GSK2879552 || LSD1 Inhibitor GSK2879552	LSD1INHIBITORGSK2879552	GSK2879552||LSD1INHIBITORGSK2879552||LSD1INHIBITORGSK2879552
Lucitanib		"1-Naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl- || AL3810 || E-3810 || LUCITANIB || Lucitanib"	LUCITANIB	"1NAPHTHALENECARBOXAMIDE,6NMETHYL||AL3810||E3810||LUCITANIB||LUCITANIB"
Luteolin	Polymer-encapsulated Luteolin Nanoparticle	"3',4',5,7-Tetrahydroxyflavone-encapsulated Polymer Nanoparticles || Nano-luteolin || Nanoluteolin || Nanoparticle-based Luteolin || Polymer-encapsulated Luteolin Nanoparticle"	POLYMERENCAPSULATEDLUTEOLINNANOPARTICLE	"3',4',5,7TETRAHYDROXYFLAVONEENCAPSULATEDPOLYMERNANOPARTICLES||NANOLUTEOLIN||NANOLUTEOLIN||NANOPARTICLEBASEDLUTEOLIN||POLYMERENCAPSULATEDLUTEOLINNANOPARTICLE"
MALT1 Inhibitor JNJ-67856633		JNJ 67856633 || JNJ-67856633 || JNJ67856633 || MALT1 Inhibitor JNJ-67856633 || MALT1 Inhibitor JNJ-67856633 || Mucosa-associated Lymphoid Tissue Lymphoma Translocation Protein 1 Inhibitor JNJ-67856633	MALT1INHIBITORJNJ67856633	JNJ67856633||JNJ67856633||JNJ67856633||MALT1INHIBITORJNJ67856633||MALT1INHIBITORJNJ67856633||MUCOSAASSOCIATEDLYMPHOIDTISSUELYMPHOMATRANSLOCATIONPROTEIN1INHIBITORJNJ67856633
Masitinib	Masitinib Mesylate	"4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide Mesylate || AB1010 || Masitinib Mesylate || Masitinib Mesylate"	MASITINIBMESYLATE	4[BENZAMIDEMESYLATE||AB1010||MASITINIBMESYLATE||MASITINIBMESYLATE
MEK 1/2 Inhibitor AS703988/MSC2015103B		AS703988 || AS703988/MSC2015103B || MEK 1/2 Inhibitor AS703988/MSC2015103B || MEK 1/2 Inhibitor AS703988/MSC2015103B || MSC2015103B	MEK1/2INHIBITORAS703988/MSC2015103B	AS703988||AS703988/MSC2015103B||MEK1/2INHIBITORAS703988/MSC2015103B||MEK1/2INHIBITORAS703988/MSC2015103B||MSC2015103B
MEK 1/2 Inhibitor FCN-159		FCN 159 || FCN-159 || FCN159 || MEK 1/2 Inhibitor FCN-159 || MEK Inhibitor FCN-159	MEK1/2INHIBITORFCN159	FCN159||FCN159||FCN159||MEK1/2INHIBITORFCN159||MEKINHIBITORFCN159
MEK Inhibitor CI-1040		"2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide || CI-1040 || MEK Inhibitor CI-1040 || PD 184352/CI-1040 || PD-184352"	MEKINHIBITORCI1040	"2NCYCLOPROPYLMETHOXY3,4DIFLUOROBENZAMIDE||CI1040||MEKINHIBITORCI1040||PD184352/CI1040||PD184352"
MEK Inhibitor TAK-733		MEK Inhibitor TAK-733 || MEK Inhibitor TAK-733 || TAK-733 || TAK-733	MEKINHIBITORTAK733	MEKINHIBITORTAK733||MEKINHIBITORTAK733||TAK733||TAK733
Menatetrenone		"2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone || E0167 || MENATETRENONE || Menaquinone K4 || Menaquinone-4 || Menatetrenone || Vitamin MK 4"	MENATETRENONE	"2METHYL3TRANSTETRAPRENYL1,4NAPHTHOQUINONE||E0167||MENATETRENONE||MENAQUINONEK4||MENAQUINONE4||MENATETRENONE||VITAMINMK4"
MET Tyrosine Kinase Inhibitor SGX523		MET Tyrosine Kinase Inhibitor SGX523 || SGX523	METTYROSINEKINASEINHIBITORSGX523	METTYROSINEKINASEINHIBITORSGX523||SGX523
Metformin	Extended Release Metformin Hydrochloride	ER Metformin Hydrochloride || Extended Release Metformin Hydrochloride || Extended Release Metformin Hydrochloride || Extended-release Metformin Hydrochloride || Glucophage XR || Glumetza || Metformin Hydrochloride Extended Release	EXTENDEDRELEASEMETFORMINHYDROCHLORIDE	ERMETFORMINHYDROCHLORIDE||EXTENDEDRELEASEMETFORMINHYDROCHLORIDE||EXTENDEDRELEASEMETFORMINHYDROCHLORIDE||EXTENDEDRELEASEMETFORMINHYDROCHLORIDE||GLUCOPHAGEXR||GLUMETZA||METFORMINHYDROCHLORIDEEXTENDEDRELEASE
Metformin	Metformin Hydrochloride	"1,1-Dimethylbiguanide Hydrochloride || APO-Metformin || Cidophage || Dimefor || Glifage || Glucoformin || Glucophage || Glucophage || Glucophage ER || METFORMIN HYDROCHLORIDE || Metformin HCl || Metformin Hydrochloride || Metformin Hydrochloride || Metformin Hydrochloride || N,N-Dimethylimidodicarbonimidic Diamide Monohydrochloride || Riomet || Siofor || metformin hydrochloride"	METFORMINHYDROCHLORIDE	"1,1DIMETHYLBIGUANIDEHYDROCHLORIDE||APOMETFORMIN||CIDOPHAGE||DIMEFOR||GLIFAGE||GLUCOFORMIN||GLUCOPHAGE||GLUCOPHAGE||GLUCOPHAGEER||METFORMINHYDROCHLORIDE||METFORMINHCL||METFORMINHYDROCHLORIDE||METFORMINHYDROCHLORIDE||METFORMINHYDROCHLORIDE||N,NDIMETHYLIMIDODICARBONIMIDICDIAMIDEMONOHYDROCHLORIDE||RIOMET||SIOFOR||METFORMINHYDROCHLORIDE"
Methotrexate		"4-Amino-10-methylfolic Acid || 4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid || Abitrexate || Alpha-Methopterin || Amethopterin || Amethopterin || Brimexate || CL 14377 || CL-14377 || Emtexate || Emthexat || Emthexate || Farmitrexat || Fauldexato || Folex || Folex || Folex PFS || Lantarel || Ledertrexate || Lumexon || METHOTREXATE || MTX || Maxtrex || Medsatrexate || Metex || Methoblastin || Methotrexate || Methotrexate || Methotrexate || Methotrexate || Methotrexate || Methotrexate || Methotrexate LPF || Methotrexate Methylaminopterin || Methotrexatum || Metotrexato || Metrotex || Mexate || Mexate-AQ || N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid || Novatrex || Rheumatrex || Rheumatrex || Texate || Tremetex || Trexeron || Trixilem || WR-19039 || amethopterin || methotrexate"	METHOTREXATE	4AMINO10METHYLFOLICACID||4AMINO4DEOXY10METHYLPTEROYLLGLUTAMICACID||ABITREXATE||ALPHAMETHOPTERIN||AMETHOPTERIN||AMETHOPTERIN||BRIMEXATE||CL14377||CL14377||EMTEXATE||EMTHEXAT||EMTHEXATE||FARMITREXAT||FAULDEXATO||FOLEX||FOLEX||FOLEXPFS||LANTAREL||LEDERTREXATE||LUMEXON||METHOTREXATE||MTX||MAXTREX||MEDSATREXATE||METEX||METHOBLASTIN||METHOTREXATE||METHOTREXATE||METHOTREXATE||METHOTREXATE||METHOTREXATE||METHOTREXATE||METHOTREXATELPF||METHOTREXATEMETHYLAMINOPTERIN||METHOTREXATUM||METOTREXATO||METROTEX||MEXATE||MEXATEAQ||N[4[[METHYL]METHYLAMINO]BENZOYL]LGLUTAMICACID||NOVATREX||RHEUMATREX||RHEUMATREX||TEXATE||TREMETEX||TREXERON||TRIXILEM||WR19039||AMETHOPTERIN||METHOTREXATE
Methotrexate	Methotrexate Sodium	METHOTREXATE SODIUM || Methotrexate Sodium || Methotrexate Sodium || Sodium Methotrexate || Trexall || Xatmep	METHOTREXATESODIUM	METHOTREXATESODIUM||METHOTREXATESODIUM||METHOTREXATESODIUM||SODIUMMETHOTREXATE||TREXALL||XATMEP
Methotrexate	Methotrexate-E Therapeutic Implant	MTX-e TI || MTX/epi gel || Methotrexate-E Therapeutic Implant || Methotrexate-E Therapeutic Implant || Methotrexate-epinephrine therapeutic implant || Methotrexate/epi	METHOTREXATEETHERAPEUTICIMPLANT	MTXETI||MTX/EPIGEL||METHOTREXATEETHERAPEUTICIMPLANT||METHOTREXATEETHERAPEUTICIMPLANT||METHOTREXATEEPINEPHRINETHERAPEUTICIMPLANT||METHOTREXATE/EPI
Methotrexate	Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles	MTX-ATMP || Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles	METHOTREXATEENCAPSULATINGAUTOLOGOUSTUMORDERIVEDMICROPARTICLES	MTXATMP||METHOTREXATEENCAPSULATINGAUTOLOGOUSTUMORDERIVEDMICROPARTICLES
Midostaurin		CGP 41251 || CGP41251 || MIDOSTAURIN || Midostaurin || Midostaurin || Midostaurin || N-Benzoyl-Staurosporine || N-Benzoylstaurosporine || N-benzoyl-staurosporine || PKC-412 || PKC412 || PKC412 || Rydapt || midostaurin	MIDOSTAURIN	CGP41251||CGP41251||MIDOSTAURIN||MIDOSTAURIN||MIDOSTAURIN||MIDOSTAURIN||NBENZOYLSTAUROSPORINE||NBENZOYLSTAUROSPORINE||NBENZOYLSTAUROSPORINE||PKC412||PKC412||PKC412||RYDAPT||MIDOSTAURIN
Mitoxantrone		"1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione || 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone || Dihydroxyanthracenedione || MITOXANTRONE || Mitoxantrone || Mitoxantrone || Mitoxantrone || Mitoxantrone || Mitozantrone || mitoxantrone"	MITOXANTRONE	"1,3DIHYDROXY5,8BIS[[2[AMINO]ETHYL]AMINO]9,10ANTHROQUINONE||DIHYDROXYANTHRACENEDIONE||MITOXANTRONE||MITOXANTRONE||MITOXANTRONE||MITOXANTRONE||MITOXANTRONE||MITOZANTRONE||MITOXANTRONE"
Mitoxantrone	Mitoxantrone Hydrochloride	"1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione Dihydrochloride || 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone Dihydrochloride || CL 232315 || DHAD || DHAD || DHAQ || DHAQ || Dihydroxyanthracenedione Dihydrochloride || MITOXANTRONE HYDROCHLORIDE || Mitoxantrone Dihydrochloride || Mitoxantrone Hydrochloride || Mitoxantrone Hydrochloride || Mitoxantroni Hydrochloridum || Mitozantrone Hydrochloride || Mitroxone || Neotalem || Novantrone || Novantrone || Onkotrone || Pralifan"	MITOXANTRONEHYDROCHLORIDE	"1,3DIHYDROXY5,8BIS[[2[AMINO]ETHYL]AMINO]9,10ANTHROQUINONEDIHYDROCHLORIDE||CL232315||DHAD||DHAD||DHAQ||DHAQ||DIHYDROXYANTHRACENEDIONEDIHYDROCHLORIDE||MITOXANTRONEHYDROCHLORIDE||MITOXANTRONEDIHYDROCHLORIDE||MITOXANTRONEHYDROCHLORIDE||MITOXANTRONEHYDROCHLORIDE||MITOXANTRONIHYDROCHLORIDUM||MITOZANTRONEHYDROCHLORIDE||MITROXONE||NEOTALEM||NOVANTRONE||NOVANTRONE||ONKOTRONE||PRALIFAN"
Mivavotinib		"3H-Pyrrolo(3,4-C)pyridin-3-one, 6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)- || MIVAVOTINIB || Mivavotinib || Spleen Tyrosine Kinase Inhibitor TAK-659 || Spleen Tyrosine Kinase Inhibitor TAK659 || TAK-659 || TAK659 || syk Inhibitor TAK-659 || syk Inhibitor TAK659 || syk-Inhibitor TAK-659 || syk-Inhibitor TAK659"	MIVAVOTINIB	3HPYRROLO||MIVAVOTINIB||MIVAVOTINIB||SPLEENTYROSINEKINASEINHIBITORTAK659||SPLEENTYROSINEKINASEINHIBITORTAK659||TAK659||TAK659||SYKINHIBITORTAK659||SYKINHIBITORTAK659||SYKINHIBITORTAK659||SYKINHIBITORTAK659
Molibresib		GSK-525762A || GSK525762 || I-BET 762 || MOLIBRESIB || Molibresib || Molibresib	MOLIBRESIB	GSK525762A||GSK525762||IBET762||MOLIBRESIB||MOLIBRESIB||MOLIBRESIB
Momelotinib		CYT387 || GS-0387 || MOMELOTINIB || Momelotinib || Momelotinib || N-(Cyanomethyl)-4-(2-((4-(morpholin-4-yl)phenyl)amino)pyrimidin-4-yl)benzamide	MOMELOTINIB	CYT387||GS0387||MOMELOTINIB||MOMELOTINIB||MOMELOTINIB||NBENZAMIDE
Motesanib		MOTESANIB || Motesanib	MOTESANIB	MOTESANIB||MOTESANIB
Motesanib	Motesanib Diphosphate	"3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-, phosphate (1:2) || AMG 706 || AMG 706 || MOTESANIB DIPHOSPHATE || Motesanib Diphosphate || Motesanib Diphosphate"	MOTESANIBDIPHOSPHATE	"3PYRIDINECARBOXAMIDE,N||AMG706||AMG706||MOTESANIBDIPHOSPHATE||MOTESANIBDIPHOSPHATE||MOTESANIBDIPHOSPHATE"
MTF-1 Inhibitor APTO-253 HCl		"2-(6-Fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Hydrochloride || APTO-253 HCl || LOR-253 HCl || LT-253 HCl || MTF-1 Inhibitor APTO-253 HCl || MTF-1 Inhibitor APTO-253 HCl"	MTF1INHIBITORAPTO253HCL	"21HIMIDAZO[4,5F][1,10]PHENANTHROLINEHYDROCHLORIDE||APTO253HCL||LOR253HCL||LT253HCL||MTF1INHIBITORAPTO253HCL||MTF1INHIBITORAPTO253HCL"
mTOR Kinase Inhibitor OSI-027		Mammalian Target of Rapamycin Kinase Inhibitor OSI-027 || OSI-027 || OSI-027 || mTOR Kinase Inhibitor OSI-027 || mTOR Kinase Inhibitor OSI-027	MTORKINASEINHIBITOROSI027	MAMMALIANTARGETOFRAPAMYCINKINASEINHIBITOROSI027||OSI027||OSI027||MTORKINASEINHIBITOROSI027||MTORKINASEINHIBITOROSI027
mTOR Kinase Inhibitor PP242		"2-(4-Amino-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-indol-5-ol || PP-242 || PP-242 || PP242 || mTOR Kinase Inhibitor PP242"	MTORKINASEINHIBITORPP242	21HINDOL5OL||PP242||PP242||PP242||MTORKINASEINHIBITORPP242
Nab-paclitaxel		ABI 007 || ABI-007 || ABI-007 || Abraxane || Abraxane || Albumin-Stabilized Nanoparticle Paclitaxel || Albumin-bound Paclitaxel || Nab-paclitaxel || Nab-paclitaxel || Nanoparticle Albumin-bound Paclitaxel || Nanoparticle Paclitaxel || Paclitaxel Albumin || Protein-bound Paclitaxel || nanoparticle paclitaxel || paclitaxel albumin-stabilized nanoparticle formulation || protein-bound paclitaxel	NABPACLITAXEL	ABI007||ABI007||ABI007||ABRAXANE||ABRAXANE||ALBUMINSTABILIZEDNANOPARTICLEPACLITAXEL||ALBUMINBOUNDPACLITAXEL||NABPACLITAXEL||NABPACLITAXEL||NANOPARTICLEALBUMINBOUNDPACLITAXEL||NANOPARTICLEPACLITAXEL||PACLITAXELALBUMIN||PROTEINBOUNDPACLITAXEL||NANOPARTICLEPACLITAXEL||PACLITAXELALBUMINSTABILIZEDNANOPARTICLEFORMULATION||PROTEINBOUNDPACLITAXEL
Nab-paclitaxel/Rituximab-coated Nanoparticle AR160		AR160 || Abraxane Coated with Rituximab 160nm Nanoparticle || Abraxane coated with Rituximab || Abraxane/Rituxan 160 Complex || Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 || Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 || Nab-paclitaxel/Rituximab-coated Nanoparticle AR160	NABPACLITAXEL/RITUXIMABCOATEDNANOPARTICLEAR160	AR160||ABRAXANECOATEDWITHRITUXIMAB160NMNANOPARTICLE||ABRAXANECOATEDWITHRITUXIMAB||ABRAXANE/RITUXAN160COMPLEX||NABPACLITAXEL/RITUXIMABCOATEDNANOPARTICLEAR160||NABPACLITAXEL/RITUXIMABCOATEDNANOPARTICLEAR160||NABPACLITAXEL/RITUXIMABCOATEDNANOPARTICLEAR160
Nanoparticle-based Paclitaxel Suspension		Nanoparticle-based Paclitaxel Suspension || Nanoparticle-based Paclitaxel Suspension || Nanotax	NANOPARTICLEBASEDPACLITAXELSUSPENSION	NANOPARTICLEBASEDPACLITAXELSUSPENSION||NANOPARTICLEBASEDPACLITAXELSUSPENSION||NANOTAX
Navitoclax		A-855071.0 || ABT-263 || ABT-263 || BcI-2 Family Protein Inhibitor ABT-263 || NAVITOCLAX || Navitoclax || Navitoclax || navitoclax	NAVITOCLAX	A855071.0||ABT263||ABT263||BCI2FAMILYPROTEININHIBITORABT263||NAVITOCLAX||NAVITOCLAX||NAVITOCLAX||NAVITOCLAX
NDDP	Liposomal NDDP	"Aroplatin || L-NDDP || Liposomal NDDP || Liposomal Neodecanoic Acid Platinum Complex || Liposomal-Cisplatin Analogue || Liposomal-Entrapped Cis-Bis-Neodecanoate-trans-R,R-1,2-Diaminocyclohexane Platinum (II)"	LIPOSOMALNDDP	"AROPLATIN||LNDDP||LIPOSOMALNDDP||LIPOSOMALNEODECANOICACIDPLATINUMCOMPLEX||LIPOSOMALCISPLATINANALOGUE||LIPOSOMALENTRAPPEDCISBISNEODECANOATETRANSR,R1,2DIAMINOCYCLOHEXANEPLATINUM"
Neratinib		"(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide || 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)- || HKI 272 || HKI-272 || NERATINIB || Neratinib || Neratinib || PB 272 || PB-272"	NERATINIB	||HKI272||HKI272||NERATINIB||NERATINIB||NERATINIB||PB272||PB272
Neratinib	Neratinib Maleate	"2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1) || HKI-272 Maleate || NERATINIB MALEATE || Neratinib Maleate || Neratinib Maleate || Nerlynx"	NERATINIBMALEATE	"2BUTENAMIDE,N||HKI272MALEATE||NERATINIBMALEATE||NERATINIBMALEATE||NERATINIBMALEATE||NERLYNX"
Nilotinib		4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide || AMN 107 Base Form || NILOTINIB || Nilotinib || Nilotinib || nilotinib	NILOTINIB	4METHYL3BENZAMIDE||AMN107BASEFORM||NILOTINIB||NILOTINIB||NILOTINIB||NILOTINIB
Nilotinib	Nilotinib Hydrochloride Anhydrous	NILOTINIB HYDROCHLORIDE ANHYDROUS || Nilotinib Hydrochloride Anhydrous	NILOTINIBHYDROCHLORIDEANHYDROUS	NILOTINIBHYDROCHLORIDEANHYDROUS||NILOTINIBHYDROCHLORIDEANHYDROUS
Nilotinib	Nilotinib Hydrochloride Monohydrate	"4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, Monohydrochloride || AMN107 || NILOTINIB HYDROCHLORIDE MONOHYDRATE || Nilotinib Hydrochloride Monohydrate || Nilotinib Hydrochloride Monohydrate || Nilotinib Monohydrochloride Monohydrate || Tasigna || Tasigna"	NILOTINIBHYDROCHLORIDEMONOHYDRATE	"4METHYLN[32PYRIMIDINYL]AMINO]BENZAMIDE,MONOHYDROCHLORIDE||AMN107||NILOTINIBHYDROCHLORIDEMONOHYDRATE||NILOTINIBHYDROCHLORIDEMONOHYDRATE||NILOTINIBHYDROCHLORIDEMONOHYDRATE||NILOTINIBMONOHYDROCHLORIDEMONOHYDRATE||TASIGNA||TASIGNA"
Niraparib		MK-4827 || MK4827 || NIRAPARIB || Niraparib || Niraparib	NIRAPARIB	MK4827||MK4827||NIRAPARIB||NIRAPARIB||NIRAPARIB
Niraparib	Niraparib Tosylate Monohydrate	"2H-Indazole-7-carboxamide, 2-(4-(3S)-3-piperidinylphenyl)-, 4-Methylbenzenesulfonate, Hydrate (1:1:1) || NIRAPARIB TOSYLATE MONOHYDRATE || Niraparib Tosylate Monohydrate || Zejula"	NIRAPARIBTOSYLATEMONOHYDRATE	"2HINDAZOLE7CARBOXAMIDE,2||NIRAPARIBTOSYLATEMONOHYDRATE||NIRAPARIBTOSYLATEMONOHYDRATE||ZEJULA"
Nivolumab		BMS-936558 || MDX-1106 || NIVO || NIVOLUMAB || Nivolumab || Nivolumab || ONO-4538 || Opdivo	NIVOLUMAB	BMS936558||MDX1106||NIVO||NIVOLUMAB||NIVOLUMAB||NIVOLUMAB||ONO4538||OPDIVO
Nutlin-3a		Nutlin-3a	NUTLIN3A	NUTLIN3A
Olaparib		AZD 2281 || AZD-2281 || AZD2281 || AZD2281 || KU-0059436 || Lynparza || OLAPARIB || Olaparib || Olaparib || PARP Inhibitor AZD2281 || PARP inhibitor AZD2281 || olaparib	OLAPARIB	AZD2281||AZD2281||AZD2281||AZD2281||KU0059436||LYNPARZA||OLAPARIB||OLAPARIB||OLAPARIB||PARPINHIBITORAZD2281||PARPINHIBITORAZD2281||OLAPARIB
Onalespib		"(2,4-Dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone || AT 13387 || AT-13387 || AT13387 || ONALESPIB || Onalespib || Onalespib"	ONALESPIB	METHANONE||AT13387||AT13387||AT13387||ONALESPIB||ONALESPIB||ONALESPIB
Oraxol		Oraxol || Oraxol || Paclitaxel-HM30181 Methanesulfonate Monohydrate || Paclitaxel/HM30181A	ORAXOL	ORAXOL||ORAXOL||PACLITAXELHM30181METHANESULFONATEMONOHYDRATE||PACLITAXEL/HM30181A
Paclitaxel		"5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester with (2R,3S)-N-Benzoyl-3-phenylisoserine || Anzatax || Asotax || Bristaxol || PACLITAXEL || Paclitaxel || Paclitaxel || Paclitaxel || Praxel || Taxol || Taxol || Taxol || Taxol Konzentrat || [2aR-[2a Alpha,4beta,4a beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester || paclitaxel"	PACLITAXEL	"5BETA,20EPOXY1,2ALPHA,4,7BETA,10BETA,13ALPHAHEXAHYDROXYTAX11EN9ONE,4,10DIACETATE2BENZOATE13ESTERWITH1A,33,4,41,5,6,9,10,11,12,12A,12BDODECAHYDRO4,11DIHYDROXY41,8,12,13TETRAMETHYL5OXO7,11METHANO1HCYCLODECA[3,4]BENZ[1,2B]OXET9YLESTER||PACLITAXEL"
Paclitaxel	Cationic Liposome-Encapsulated Paclitaxel	Cationic Liposome-Encapsulated Paclitaxel || EndoTAG-1 || LipoPac || MBT-0206	CATIONICLIPOSOMEENCAPSULATEDPACLITAXEL	CATIONICLIPOSOMEENCAPSULATEDPACLITAXEL||ENDOTAG1||LIPOPAC||MBT0206
Paclitaxel	Mucoadhesive Paclitaxel Formulation	DHP107 || Mucoadhesive Paclitaxel Formulation || Mucoadhesive Paclitaxel Formulation	MUCOADHESIVEPACLITAXELFORMULATION	DHP107||MUCOADHESIVEPACLITAXELFORMULATION||MUCOADHESIVEPACLITAXELFORMULATION
Paclitaxel	Nanoparticle Paclitaxel Ointment SOR007	NanoPac Ointment || Nanopartcle Paclitaxel SOR007 || Nanoparticle Paclitaxel Ointment SOR007 || Nanoparticle Paclitaxel Ointment SOR007 || SOR007 || SOR007 Ointment || Topical Nanoparticle Paclitaxel Ointment || Uncoated Nanoparticle Paclitaxel Ointment	NANOPARTICLEPACLITAXELOINTMENTSOR007	NANOPACOINTMENT||NANOPARTCLEPACLITAXELSOR007||NANOPARTICLEPACLITAXELOINTMENTSOR007||NANOPARTICLEPACLITAXELOINTMENTSOR007||SOR007||SOR007OINTMENT||TOPICALNANOPARTICLEPACLITAXELOINTMENT||UNCOATEDNANOPARTICLEPACLITAXELOINTMENT
Paclitaxel	Paclitaxel Ceribate	"7beta-((2RS)-2,3-dihydroxypropoxycarbonyloxy)-1-hydroxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,10beta,13alpha-tetrayl 4,10-diacetate 2-benzoate 13-((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate) || PACLITAXEL CERIBATE || Paclitaxel Ceribate"	PACLITAXELCERIBATE	7BETA||PACLITAXELCERIBATE||PACLITAXELCERIBATE
Paclitaxel	Paclitaxel Injection Concentrate for Nanodispersion	PICN || Paclitaxel Injection Concentrate for Nanodispersion || Paclitaxel Injection Concentrate for Nanodispersion	PACLITAXELINJECTIONCONCENTRATEFORNANODISPERSION	PICN||PACLITAXELINJECTIONCONCENTRATEFORNANODISPERSION||PACLITAXELINJECTIONCONCENTRATEFORNANODISPERSION
Paclitaxel	Paclitaxel Liposome	LEP-ETU || LipoTaxen || Liposome-Encapsulated Paclitaxel || PNU-93914 || Paclitaxel Liposome || liposomal paclitaxel || paclitaxel liposome	PACLITAXELLIPOSOME	LEPETU||LIPOTAXEN||LIPOSOMEENCAPSULATEDPACLITAXEL||PNU93914||PACLITAXELLIPOSOME||LIPOSOMALPACLITAXEL||PACLITAXELLIPOSOME
Paclitaxel	Paclitaxel Poliglumex	CT-2103 || CT-2103 || CT2103 || PACLITAXEL POLIGLUMEX || PG-TXL || Paclitaxel Poliglumex || Paclitaxel Poliglumex || Paclitaxel Polyglutamate || Paclitaxel-Polyglutamate Polymer || Poly-L-Glutamic acid-Paclitaxel Conjugate || Polyglutamic Acid Paclitaxel || Xyotax || Xyotax || paclitaxel poliglumex || paclitaxel polyglutamate	PACLITAXELPOLIGLUMEX	CT2103||CT2103||CT2103||PACLITAXELPOLIGLUMEX||PGTXL||PACLITAXELPOLIGLUMEX||PACLITAXELPOLIGLUMEX||PACLITAXELPOLYGLUTAMATE||PACLITAXELPOLYGLUTAMATEPOLYMER||POLYLGLUTAMICACIDPACLITAXELCONJUGATE||POLYGLUTAMICACIDPACLITAXEL||XYOTAX||XYOTAX||PACLITAXELPOLIGLUMEX||PACLITAXELPOLYGLUTAMATE
Paclitaxel	Paclitaxel Polymeric Micelle Formulation NANT-008	Cynviloq || Genexol-PM || IG-001 || Micellar Nanoparticle-encapsulated NANT-008 || NANT 008 || NANT-008 || NANT008 || Nant-paclitaxel || Paclitaxel Polymeric Micelle Formulation NANT-008 || Paclitaxel-loaded Micellar Diblock Copolymer NANT-008 || Paclitaxel-loaded Polymeric Micelle NANT-008	PACLITAXELPOLYMERICMICELLEFORMULATIONNANT008	CYNVILOQ||GENEXOLPM||IG001||MICELLARNANOPARTICLEENCAPSULATEDNANT008||NANT008||NANT008||NANT008||NANTPACLITAXEL||PACLITAXELPOLYMERICMICELLEFORMULATIONNANT008||PACLITAXELLOADEDMICELLARDIBLOCKCOPOLYMERNANT008||PACLITAXELLOADEDPOLYMERICMICELLENANT008
Paclitaxel	Paclitaxel PPE Microspheres	Paclimer Microspheres || Paclimer Microspheres (Polilactofate/Paclitaxel) || Paclitaxel Biopolymer Formulation || Paclitaxel PPE Microspheres	PACLITAXELPPEMICROSPHERES	PACLIMERMICROSPHERES||PACLIMERMICROSPHERES||PACLITAXELBIOPOLYMERFORMULATION||PACLITAXELPPEMICROSPHERES
Paclitaxel	Paclitaxel Trevatide	ANG-1005 || ANG1005 || GRN1005 || PACLITAXEL TREVATIDE || Paclitaxel Trevatide || Paclitaxel Trevatide	PACLITAXELTREVATIDE	ANG1005||ANG1005||GRN1005||PACLITAXELTREVATIDE||PACLITAXELTREVATIDE||PACLITAXELTREVATIDE
Paclitaxel	Paclitaxel Vitamin E-Based Emulsion	PIE || Paclitaxel Injectable Emulsion || Paclitaxel Vitamin E-Based Emulsion || S-8184 || Tocosol	PACLITAXELVITAMINEBASEDEMULSION	PIE||PACLITAXELINJECTABLEEMULSION||PACLITAXELVITAMINEBASEDEMULSION||S8184||TOCOSOL
Paclitaxel	Paclitaxel-Loaded Polymeric Micelle	Cynviloq TM || Genexol PM || IG-001 || Paclitaxel-Loaded Polymeric Micelle || paclitaxel-loaded polymeric micelle	PACLITAXELLOADEDPOLYMERICMICELLE	CYNVILOQTM||GENEXOLPM||IG001||PACLITAXELLOADEDPOLYMERICMICELLE||PACLITAXELLOADEDPOLYMERICMICELLE
Paclitaxel	Pegylated Paclitaxel	PEG Paclitaxel || Pegylated Paclitaxel	PEGYLATEDPACLITAXEL	PEGPACLITAXEL||PEGYLATEDPACLITAXEL
Paclitaxel	PEOX-based Polymer Encapsulated Paclitaxel FID-007	FID 007 || FID-007 || FID007 || Nanoencapsulated Paclitaxel FID-007 || PEOX-based Polymer Encapsulated Paclitaxel FID-007 || PEOX-based Polymer Encapsulated Paclitaxel FID-007 || Paclitaxel in Polyethyloxazoline Polymer	PEOXBASEDPOLYMERENCAPSULATEDPACLITAXELFID007	FID007||FID007||FID007||NANOENCAPSULATEDPACLITAXELFID007||PEOXBASEDPOLYMERENCAPSULATEDPACLITAXELFID007||PEOXBASEDPOLYMERENCAPSULATEDPACLITAXELFID007||PACLITAXELINPOLYETHYLOXAZOLINEPOLYMER
Paclitaxel	PGLA/PEG Copolymer-Based Paclitaxel	OncoGel || PGLA/PEG Copolymer-Based Paclitaxel || PGLA/PEG Copolymer-Based Paclitaxel	PGLA/PEGCOPOLYMERBASEDPACLITAXEL	ONCOGEL||PGLA/PEGCOPOLYMERBASEDPACLITAXEL||PGLA/PEGCOPOLYMERBASEDPACLITAXEL
Paclitaxel	Submicron Particle Paclitaxel Sterile Suspension	NanoPac || Sterile Nanoparticle-based Paclitaxel Suspension || Sterile Nanoparticulate Paclitaxel || Submicron Particle Paclitaxel || Submicron Particle Paclitaxel Formulation || Submicron Particle Paclitaxel Sterile Suspension || Submicron Particle Paclitaxel Sterile Suspension	SUBMICRONPARTICLEPACLITAXELSTERILESUSPENSION	NANOPAC||STERILENANOPARTICLEBASEDPACLITAXELSUSPENSION||STERILENANOPARTICULATEPACLITAXEL||SUBMICRONPARTICLEPACLITAXEL||SUBMICRONPARTICLEPACLITAXELFORMULATION||SUBMICRONPARTICLEPACLITAXELSTERILESUSPENSION||SUBMICRONPARTICLEPACLITAXELSTERILESUSPENSION
Paclitaxel	Vector-peptide Conjugated Paclitaxel	Taxol-Angiopep Conjugate || Vector-peptide Conjugated Paclitaxel	VECTORPEPTIDECONJUGATEDPACLITAXEL	TAXOLANGIOPEPCONJUGATE||VECTORPEPTIDECONJUGATEDPACLITAXEL
Palbociclib		"6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one || Ibrance || PALBOCICLIB || PD 0332991 || PD 332991 || PD 991 || PD-0332991 || Palbociclib || Palbociclib || Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"	PALBOCICLIB	6ACETYL8CYCLOPENTYL5METHYL2
Palbociclib	Palbociclib Isethionate	"6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino(pyrido(2,3-d)pyrimidin-7(8h)-one mono(2-hydroxyethanesulfonate) || PALBOCICLIB ISETHIONATE || PD 0332991-0054 || PF-00080665-73 || Palbociclib Isethionate || Palbociclib Isethionate"	PALBOCICLIBISETHIONATE	6ACETYL8CYCLOPENTYL5METHYL2||PALBOCICLIBISETHIONATE||PD03329910054||PF0008066573||PALBOCICLIBISETHIONATE||PALBOCICLIBISETHIONATE
Pan-AKT Kinase Inhibitor GSK690693		GSK690693 || Pan-AKT Kinase Inhibitor GSK690693 || Pan-AKT Kinase Inhibitor GSK690693	PANAKTKINASEINHIBITORGSK690693	GSK690693||PANAKTKINASEINHIBITORGSK690693||PANAKTKINASEINHIBITORGSK690693
Panobinostat		(2E)-N-hydroxy-3-(4-(((2-(2-methyl-1h-indol-3-yl)ethyl)amino)methyl)phenyl)prop-2-enamide || Faridak || Faridak || Farydak || LBH589 || LBH589 || PANOBINOSTAT || Panobinostat || Panobinostat || panobinostat	PANOBINOSTAT	PROP2ENAMIDE||FARIDAK||FARIDAK||FARYDAK||LBH589||LBH589||PANOBINOSTAT||PANOBINOSTAT||PANOBINOSTAT||PANOBINOSTAT
Panobinostat	Panobinostat Nanoparticle Formulation MTX110	MTX 110 || MTX-110 || MTX110 || Panobinostat Nanoparticle Formulation MTX110 || Panobinostat Nanoparticle Formulation MTX110	PANOBINOSTATNANOPARTICLEFORMULATIONMTX110	MTX110||MTX110||MTX110||PANOBINOSTATNANOPARTICLEFORMULATIONMTX110||PANOBINOSTATNANOPARTICLEFORMULATIONMTX110
Pazopanib		"Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl- || GW786034 || GW786034 || PAZOPANIB || Pazopanib"	PAZOPANIB	"BENZENESULFONAMIDE,52METHYL||GW786034||GW786034||PAZOPANIB||PAZOPANIB"
Pazopanib	Pazopanib Hydrochloride	"5-((4-((2,3-Dimethyl-2h-Indazol-6-Yl)Methylamino)Pyrimidin-2-yl)Amino)-2-Methylbenzenesulfonamide Monohydrochloride || GW786034B || PAZOPANIB HYDROCHLORIDE || Pazopanib Hydrochloride || Pazopanib Hydrochloride || Votrient || Votrient || pazopanib hydrochloride"	PAZOPANIBHYDROCHLORIDE	52METHYLBENZENESULFONAMIDEMONOHYDROCHLORIDE||GW786034B||PAZOPANIBHYDROCHLORIDE||PAZOPANIBHYDROCHLORIDE||PAZOPANIBHYDROCHLORIDE||VOTRIENT||VOTRIENT||PAZOPANIBHYDROCHLORIDE
Pelitinib		(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide || EKB 569 || EKB-569 || EKB-569 || PELITINIB || Pelitinib || Pelitinib || WAY-EKB 569	PELITINIB	BUT2ENAMIDE||EKB569||EKB569||EKB569||PELITINIB||PELITINIB||PELITINIB||WAYEKB569
Pembrolizumab		"Immunoglobulin G4, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal (228-L-proline(H10-S>P))gamma 4 Heavy Chain (134-218')-disulfide with Humanized Mouse Monoclonal Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide || Keytruda || Lambrolizumab || MK-3475 || PEMBROLIZUMAB || Pembrolizumab || Pembrolizumab || SCH 900475"	PEMBROLIZUMAB	"IMMUNOGLOBULING4,ANTIBISDISULFIDE||KEYTRUDA||LAMBROLIZUMAB||MK3475||PEMBROLIZUMAB||PEMBROLIZUMAB||PEMBROLIZUMAB||SCH900475"
Pemetrexed		"L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl) || MTA || Multitargeted Antifolate || PEMETREXED || Pemetrexed || Pemetrexed"	PEMETREXED	"LGLUTAMICACID,N||MTA||MULTITARGETEDANTIFOLATE||PEMETREXED||PEMETREXED||PEMETREXED"
Pemetrexed	Pemetrexed Disodium	"Alimta || Alimta || Almita || LY231514 || LY231514 || N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt || N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt || PEMETREXED DISODIUM || Pemetrexed Disodium || Pemetrexed Disodium || pemetrexed disodium"	PEMETREXEDDISODIUM	ALIMTA||ALIMTA||ALMITA||LY231514||LY231514||N[4[2ETHYL]BENZOYL]LGLUTAMICACIDDISODIUMSALT||PEMETREXEDDISODIUM||PEMETREXEDDISODIUM||PEMETREXEDDISODIUM||PEMETREXEDDISODIUM
Pertuzumab		"2C4 || 2C4 Antibody || Immunoglobulin G1, Anti-(Human V (Receptor)) (Human-Mouse Monoclonal 2C4 Heavy Chain), Disulfide with Human-Mouse Monoclonal 2C4 Kappa-Chain, Dimer || MoAb 2C4 || Monoclonal Antibody 2C4 || Omnitarg || PERTUZUMAB || Perjeta || Pertuzumab || Pertuzumab || RO4368451 || pertuzumab || rhuMAb2C4"	PERTUZUMAB	"2C4||2C4ANTIBODY||IMMUNOGLOBULING1,ANTI,DISULFIDEWITHHUMANMOUSEMONOCLONAL2C4KAPPACHAIN,DIMER||MOAB2C4||MONOCLONALANTIBODY2C4||OMNITARG||PERTUZUMAB||PERJETA||PERTUZUMAB||PERTUZUMAB||RO4368451||PERTUZUMAB||RHUMAB2C4"
Pictilisib		"2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine || 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine || GDC 0941 || GDC-0941 || GDC0941 || PICTILISIB || Pictilisib"	PICTILISIB	2MORPHOLINE||GDC0941||GDC0941||GDC0941||PICTILISIB||PICTILISIB
Plk1 Inhibitor BI 2536		BI 2536 || BI 2536 || BI-2536 || Plk1 Inhibitor BI 2536 || Plk1 Inhibitor BI 2536	PLK1INHIBITORBI2536	BI2536||BI2536||BI2536||PLK1INHIBITORBI2536||PLK1INHIBITORBI2536
Pomalidomide		"3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide || 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione || 4-Aminothalidomide || Actimid || CC-4047 || CC-4047 || Imnovid || POMALIDOMIDE || Pomalidomide || Pomalidomide || Pomalyst || pomalidomide"	POMALIDOMIDE	"3AMINONISOINDOLINE1,3DIONE||4AMINOTHALIDOMIDE||ACTIMID||CC4047||CC4047||IMNOVID||POMALIDOMIDE||POMALIDOMIDE||POMALIDOMIDE||POMALYST||POMALIDOMIDE"
Ponatinib		"AP-24534 || AP24534 || Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl) || PONATINIB || Ponatinib"	PONATINIB	"AP24534||AP24534||BENZAMIDE,3||PONATINIB||PONATINIB"
Ponatinib	Ponatinib Hydrochloride	"AP24534 HCl || Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)-, Hydrochloride (1:1) || Iclusig || PONATINIB HYDROCHLORIDE || Ponatinib Hydrochloride || Ponatinib Hydrochloride"	PONATINIBHYDROCHLORIDE	"AP24534HCL||BENZAMIDE,3||ICLUSIG||PONATINIBHYDROCHLORIDE||PONATINIBHYDROCHLORIDE||PONATINIBHYDROCHLORIDE"
Prostate Health Cocktail Dietary Supplement		Cholecalciferol/d-Alpha Tocopherol/L-Selenomethionine/Green Tea Extract/Saw Palmetto Berry Extract/Daidzein/Genistein/Lycopene Prostate Health Supplement || PHC || Prostate Health Cocktail || Prostate Health Cocktail Dietary Supplement || Prostate Health Cocktail Dietary Supplement	PROSTATEHEALTHCOCKTAILDIETARYSUPPLEMENT	CHOLECALCIFEROL/DALPHATOCOPHEROL/LSELENOMETHIONINE/GREENTEAEXTRACT/SAWPALMETTOBERRYEXTRACT/DAIDZEIN/GENISTEIN/LYCOPENEPROSTATEHEALTHSUPPLEMENT||PHC||PROSTATEHEALTHCOCKTAIL||PROSTATEHEALTHCOCKTAILDIETARYSUPPLEMENT||PROSTATEHEALTHCOCKTAILDIETARYSUPPLEMENT
Quizartinib		"(2E)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3S)-Oxolan-3-Yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)but-2-Enamide || AC-220 || AC010220 || AC220 || N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo [2,1-b] [1,3] benzothiazol 2-yl]phenyl}urea || QUIZARTINIB || Quizartinib || Quizartinib || Quizartinib"	QUIZARTINIB	"IMIDAZO[2,1B][1,3]BENZOTHIAZOL2YL]PHENYL}UREA||QUIZARTINIB||QUIZARTINIB||QUIZARTINIB||QUIZARTINIB"
Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88		Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus Combination SM88 || Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88 || Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88 || SM-88 || SM-88 Used with MPS || SM-88 Used with Methoxsalen/Phenytoin/Sirolimus || SM-88/Methoxsalen/Phenytoin/Sirolimus || Tyrosine Isomers/Phenytoin/Methoxsalen/Sirolimus	RACEMETYROSINE/METHOXSALEN/PHENYTOIN/SIROLIMUSSM88	RACEMETYROSINE/METHOXSALEN/PHENYTOIN/SIROLIMUSCOMBINATIONSM88||RACEMETYROSINE/METHOXSALEN/PHENYTOIN/SIROLIMUSSM88||RACEMETYROSINE/METHOXSALEN/PHENYTOIN/SIROLIMUSSM88||SM88||SM88USEDWITHMPS||SM88USEDWITHMETHOXSALEN/PHENYTOIN/SIROLIMUS||SM88/METHOXSALEN/PHENYTOIN/SIROLIMUS||TYROSINEISOMERS/PHENYTOIN/METHOXSALEN/SIROLIMUS
Radgocitabine		4-Amino-L-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)- 2(1H)-pyrimidinone || CNDAC || Deoxycytidine Analogue TAS-109 || RADGOCITABINE || Radgocitabine || Radgocitabine || TAS-109	RADGOCITABINE	4AMINOLPYRIMIDINONE||CNDAC||DEOXYCYTIDINEANALOGUETAS109||RADGOCITABINE||RADGOCITABINE||RADGOCITABINE||TAS109
Ralimetinib	Ralimetinib Mesylate	"3H-Imidazo(4,5-b)pyridin-2-amine, 5-(2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-, Methanesulfonate (1:2) || LY-2228820 || LY2228820 || LY2228820 Dimesylate || RALIMETINIB MESYLATE || Ralimetinib Dimesylate || Ralimetinib Mesylate || Ralimetinib Mesylate"	RALIMETINIBMESYLATE	3HIMIDAZO||LY2228820||LY2228820||LY2228820DIMESYLATE||RALIMETINIBMESYLATE||RALIMETINIBDIMESYLATE||RALIMETINIBMESYLATE||RALIMETINIBMESYLATE
Raloxifene		Keoxifene || LY 139481 || RALOXIFENE || Raloxifene || Raloxifene || Raloxifene || [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone || raloxifene	RALOXIFENE	KEOXIFENE||LY139481||RALOXIFENE||RALOXIFENE||RALOXIFENE||RALOXIFENE||[6HYDROXY2ETHOXY]PHENYL]METHANONE||RALOXIFENE
Raloxifene	Raloxifene Hydrochloride	(6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone Hydrochloride || Evista || Evista || Evista || Keoxifene Hydrochloride || LY-156758 || Optruma || RALOXIFENE HYDROCHLORIDE || Raloxifene HCl || Raloxifene Hydrochloride || Raloxifene Hydrochloride || Raloxifene hydrochloride || Raloxifene.HCl || raloxifene hydrochloride	RALOXIFENEHYDROCHLORIDE	METHANONEHYDROCHLORIDE||EVISTA||EVISTA||EVISTA||KEOXIFENEHYDROCHLORIDE||LY156758||OPTRUMA||RALOXIFENEHYDROCHLORIDE||RALOXIFENEHCL||RALOXIFENEHYDROCHLORIDE||RALOXIFENEHYDROCHLORIDE||RALOXIFENEHYDROCHLORIDE||RALOXIFENE.HCL||RALOXIFENEHYDROCHLORIDE
Ranolazine		"1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy- 3-(2-methoxyphenoxy)propyl)- || RANOLAZINE || Ranexa || Ranolazine || Ranolazine"	RANOLAZINE	"1PIPERAZINEACETAMIDE,N||RANOLAZINE||RANEXA||RANOLAZINE||RANOLAZINE"
Rapamycin	Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201	Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 || RAPA 201 || RAPA-201 || RAPA201	AUTOLOGOUSRAPAMYCINRESISTANTTH1/TC1CELLSRAPA201	AUTOLOGOUSRAPAMYCINRESISTANTTH1/TC1CELLSRAPA201||RAPA201||RAPA201||RAPA201
Rapamycin	Encapsulated Rapamycin	Encapsulated Rapamycin || Encapsulated Rapamycin || Encapsulated Sirolimus || Microencapsulated Rapamycin || eRapa (TM)	ENCAPSULATEDRAPAMYCIN	ENCAPSULATEDRAPAMYCIN||ENCAPSULATEDRAPAMYCIN||ENCAPSULATEDSIROLIMUS||MICROENCAPSULATEDRAPAMYCIN||ERAPA
Rapamycin	Nanoparticle Albumin-Bound Rapamycin	ABI-009 || Nab-Rapamycin || Nanoparticle Albumin-Bound Rapamycin || Nanoparticle Albumin-Bound Rapamycin	NANOPARTICLEALBUMINBOUNDRAPAMYCIN	ABI009||NABRAPAMYCIN||NANOPARTICLEALBUMINBOUNDRAPAMYCIN||NANOPARTICLEALBUMINBOUNDRAPAMYCIN
Regorafenib		4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide || BAY 73-4506 || REGORAFENIB || Regorafenib || Regorafenib || Stivarga	REGORAFENIB	4NMETHYLPYRIDINE2CARBOXAMIDE||BAY734506||REGORAFENIB||REGORAFENIB||REGORAFENIB||STIVARGA
Resveratrol		"(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol || 3,4',5-Stilbenetriol || RESVERATROL || RESVERATROL || Resveratrol || Resveratrol || Resveratrol || resveratrol"	RESVERATROL	"ETHENYL]1,3BENZENEDIOL||3,4',5STILBENETRIOL||RESVERATROL||RESVERATROL||RESVERATROL||RESVERATROL||RESVERATROL||RESVERATROL"
Resveratrol	Resveratrol Formulation SRT501	Resveratrol Formulation SRT501 || SRT501	RESVERATROLFORMULATIONSRT501	RESVERATROLFORMULATIONSRT501||SRT501
Retaspimycin		"17-Allylamino-17-demethoxygeldanamycin Hydroquinone || Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)- || RETASPIMYCIN || Retaspimycin"	RETASPIMYCIN	"17ALLYLAMINO17DEMETHOXYGELDANAMYCINHYDROQUINONE||GELDANAMYCIN,18,21DIDEHYDRO17DEMETHOXY18,21DIDEOXO18,21DIHYDROXY17||RETASPIMYCIN||RETASPIMYCIN"
Retaspimycin	Retaspimycin Hydrochloride	"17-Allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride || Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-, monohydrochloride || IPI-504 || RETASPIMYCIN HYDROCHLORIDE || Retaspimycin Hydrochloride || Retaspimycin Hydrochloride"	RETASPIMYCINHYDROCHLORIDE	"17ALLYLAMINO17DEMETHOXYGELDANAMYCINHYDROQUINONEHYDROCHLORIDE||GELDANAMYCIN,18,21DIDEHYDRO17DEMETHOXY18,21DIDEOXO18,21DIHYDROXY17,MONOHYDROCHLORIDE||IPI504||RETASPIMYCINHYDROCHLORIDE||RETASPIMYCINHYDROCHLORIDE||RETASPIMYCINHYDROCHLORIDE"
Ribociclib/Letrozole		Kisqali and Femara Co-pack || Kisqali/Femara || Ribociclib + Letrozole || Ribociclib Plus Letrozole || Ribociclib and Letrozole Co-pack || Ribociclib-Letrozole || Ribociclib-Letrozole Regimen || Ribociclib/Letrozole	RIBOCICLIB/LETROZOLE	KISQALIANDFEMARACOPACK||KISQALI/FEMARA||RIBOCICLIB+LETROZOLE||RIBOCICLIBPLUSLETROZOLE||RIBOCICLIBANDLETROZOLECOPACK||RIBOCICLIBLETROZOLE||RIBOCICLIBLETROZOLEREGIMEN||RIBOCICLIB/LETROZOLE
Ridaforolimus		"AP23573 || AP23573 || Deforolimus || MK-8669 || RIDAFOROLIMUS || Rapamycin, 42-(dimethylphosphinate) || Ridaforolimus || Ridaforolimus || ridaforolimus"	RIDAFOROLIMUS	"AP23573||AP23573||DEFOROLIMUS||MK8669||RIDAFOROLIMUS||RAPAMYCIN,42||RIDAFOROLIMUS||RIDAFOROLIMUS||RIDAFOROLIMUS"
Rofecoxib		4-[4'-(Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone || MK 966 || ROFECOXIB || Rofecoxib || Rofecoxib || Vioxx || Vioxx || rofecoxib	ROFECOXIB	4[4'FURANONE||MK966||ROFECOXIB||ROFECOXIB||ROFECOXIB||VIOXX||VIOXX||ROFECOXIB
Romidepsin		"Antibiotic FR 901228 || Depsipeptide || FK228 || FR901228 || FR901228 || Istodax || L-Valine, N- (3-hydroxy-7-mercapto-1-oxo-4-heptenyl)valyl- cysteinyl-2, 3-didehydro-2-aminobutanoyl-,xi-lactone, cyclic (1-2)-disulfide || L-Valine, N-(3-Hydroxy-7-Mercapto-1-Oxo-4-Heptenyl)-D-Valyl-D-Cysteinyl-(Z)-2,3 -Didehydro-2-Aminobutanoyl-, xi-Lactone, Cyclic (1-2)-Disulfide, (S-(E))- || N-[(3S,4E)-3-Hydroxy-7-mercapto-1-oxo-4-heptenyl]-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoyl-L-valine, (4-1) Lactone, Cyclic || N-[(3S,4E)-3-Hydroxy-7-mercapto-1-oxo-4-heptenyl]-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoyl-L-valine, (4->1) Lactone, Cyclic || ROMIDEPSIN || Romidepsin || Romidepsin || depsipeptide || romidepsin"	ROMIDEPSIN	"ANTIBIOTICFR901228||DEPSIPEPTIDE||FK228||FR901228||FR901228||ISTODAX||LVALINE,NLACTONE,CYCLIC||ROMIDEPSIN||ROMIDEPSIN||ROMIDEPSIN||DEPSIPEPTIDE||ROMIDEPSIN"
Ropidoxuridine		"2(1H)-Pyrimidinone, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-iodo- || 5-Iodo-2-pyrimidinone 2' deoxyribonucleoside || 5-Iodo-2-pyrimidinone-2'-deoxyribose || IPdR || ROPIDOXURIDINE || Ropidoxuridine || Ropidoxuridine"	ROPIDOXURIDINE	25IODO||5IODO2PYRIMIDINONE2'DEOXYRIBONUCLEOSIDE||5IODO2PYRIMIDINONE2'DEOXYRIBOSE||IPDR||ROPIDOXURIDINE||ROPIDOXURIDINE||ROPIDOXURIDINE
Ruxolitinib		"(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile || INCB-18424 || INCB18424 || Jakafi || Oral JAK Inhibitor INCB18424 || RUXOLITINIB || Ruxolitinib || Ruxolitinib"	RUXOLITINIB	PROPANENITRILE||INCB18424||INCB18424||JAKAFI||ORALJAKINHIBITORINCB18424||RUXOLITINIB||RUXOLITINIB||RUXOLITINIB
Sacituzumab Govitecan		IMMU-132 || RS7-SN38 || SACITUZUMAB GOVITECAN || Sacituzumab Govitecan || Sacituzumab Govitecan || Sacituzumab Govitecan-hziy || Trodelvy || hRS7-SN38 Antibody Drug Conjugate	SACITUZUMABGOVITECAN	IMMU132||RS7SN38||SACITUZUMABGOVITECAN||SACITUZUMABGOVITECAN||SACITUZUMABGOVITECAN||SACITUZUMABGOVITECANHZIY||TRODELVY||HRS7SN38ANTIBODYDRUGCONJUGATE
Sapanisertib		INK-128 || INK128 || MLN-0128 || MLN0128 || SAPANISERTIB || Sapanisertib || Sapanisertib || TAK-228	SAPANISERTIB	INK128||INK128||MLN0128||MLN0128||SAPANISERTIB||SAPANISERTIB||SAPANISERTIB||TAK228
Saracatinib		"4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]- || AZD0530 || AZD0530 || N-(5-Chloro-1,3-Benzodioxol-4-Yl)-7-(2-(4-Methylpiperazin-1-yl)Ethoxy)-5-((Oxan-4-yl)Oxy)Quinazolin-4-Amine || SARACATINIB || SRC Kinase Inhibitor AZD0530 || Saracatinib || Saracatinib"	SARACATINIB	"4QUINAZOLINAMINE,NQUINAZOLIN4AMINE||SARACATINIB||SRCKINASEINHIBITORAZD0530||SARACATINIB||SARACATINIB"
Saracatinib	Saracatinib Difumarate	"4-Quinazolinamine, N-(5-Chloro-1,3-Benzodioxol-4-yl)-7-(2-(4-Methyl-1-Piperazinyl)Ethoxy)-5-((Tetrahydro-2H-Pyran-4-yl)Oxy)-, (2e)-2-Butenedioate (1:2) || AZD-0530 Difumarate || AZD0530 Difumarate || N-(5-Chloro-1,3-Benzodioxol-4-yl)-7-(2-(4-Methylpiperazin-1-yl)Ethoxy)-5-(Tetrahydro-2H-Pyran-4-yloxy)Quinazolin-4-Amine Di((2e)-but-2-Enedioate) || SARACATINIB DIFUMARATE || Saracatinib Difumarate"	SARACATINIBDIFUMARATE	"4QUINAZOLINAMINE,N||SARACATINIBDIFUMARATE||SARACATINIBDIFUMARATE"
Satraplatin		"(OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum || (OC-6-43)-bis(acetato-O)amminedichloro(cyclohexanamine)platinum || BMS-182751 || BMY-45594 || JM 216 || JM-216 || Orplatna || SATRAPLATIN || Satraplatin || Satraplatin || platinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43) || satraplatin"	SATRAPLATIN	||SATRAPLATIN
Scopoletin		"2H-1-Benzopyran-2-One, 7-Hydroxy-6-Methoxy- || 2H-1-Benzopyran-2-One, 7-Hydroxy-6-Methoxy- (9CI) || 6-Methoxyumbelliferone || 6-Methylesculetin || 6-O-Methylesculetin || 7-Hydroxy-5-Methoxycoumarin || 7-Hydroxy-6-Methoxychromen-2-One || 7-Hydroxy-6-Methoxycoumarin || Chrysatropic Acid || Coumarin, 7-Hydroxy-6-Methoxy- || Escopoletin || Esculetin-6-Methyl Ether || Gelseminic Acid || Methylesculetin || Murrayetin || Scopoletin || Scopoletin || Scopoletine || Scopoletol"	SCOPOLETIN	"2H1BENZOPYRAN2ONE,7HYDROXY6METHOXY||2H1BENZOPYRAN2ONE,7HYDROXY6METHOXY||6METHOXYUMBELLIFERONE||6METHYLESCULETIN||6OMETHYLESCULETIN||7HYDROXY5METHOXYCOUMARIN||7HYDROXY6METHOXYCHROMEN2ONE||7HYDROXY6METHOXYCOUMARIN||CHRYSATROPICACID||COUMARIN,7HYDROXY6METHOXY||ESCOPOLETIN||ESCULETIN6METHYLETHER||GELSEMINICACID||METHYLESCULETIN||MURRAYETIN||SCOPOLETIN||SCOPOLETIN||SCOPOLETINE||SCOPOLETOL"
Seliciclib		CYC202 || R-roscovitine || SELICICLIB || Seliciclib || Seliciclib	SELICICLIB	CYC202||RROSCOVITINE||SELICICLIB||SELICICLIB||SELICICLIB
Selinexor		"2-Propenoic Acid, 3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-Pyrazinyl)hydrazide, (2Z)- || ATG-010 || CRM1 Nuclear Export Inhibitor KPT-330 || KPT-330 || SELINEXOR || SINE KPT-330 || Selective Inhibitor of Nuclear Export KPT-330 || Selinexor || Selinexor || Xpovio"	SELINEXOR	"2PROPENOICACID,3||ATG010||CRM1NUCLEAREXPORTINHIBITORKPT330||KPT330||SELINEXOR||SINEKPT330||SELECTIVEINHIBITOROFNUCLEAREXPORTKPT330||SELINEXOR||SELINEXOR||XPOVIO"
Selumetinib		ARRY-142886 || AZD6244 || AZD6244 || MEK Inhibitor AZD6244 || MEK inhibitor AZD6244 || SELUMETINIB || Selumetinib || Selumetinib	SELUMETINIB	ARRY142886||AZD6244||AZD6244||MEKINHIBITORAZD6244||MEKINHIBITORAZD6244||SELUMETINIB||SELUMETINIB||SELUMETINIB
Selumetinib	Selumetinib Sulfate	"1H-Benzimidazole-6-Carboxamide, 5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulfate (1:1) || 1h-Benzimidazole-6-Carboxamide,5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulphate (1:1) || 5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulfate || 5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulphate || AZD-6244 Hydrogen Sulfate || AZD6244 Hydrogen Sulfate || AZD6244 Hydrogen Sulphate || Koselugo || SELUMETINIB SULFATE || Selumetinib Sulfate || Selumetinib Sulfate || Selumetinib Sulphate"	SELUMETINIBSULFATE	"1HBENZIMIDAZOLE6CARBOXAMIDE,51METHYL1HBENZIMIDAZOLE6CARBOXAMIDESULPHATE||AZD6244HYDROGENSULFATE||AZD6244HYDROGENSULFATE||AZD6244HYDROGENSULPHATE||KOSELUGO||SELUMETINIBSULFATE||SELUMETINIBSULFATE||SELUMETINIBSULFATE||SELUMETINIBSULPHATE"
Sepantronium	Sepantronium Bromide	"1H-Naphth(2,3-d)imidazolium, 4,9-dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazinylmethyl)-, Bromide || SEPANTRONIUM BROMIDE || Sepantronium Bromide || Sepantronium Bromide || Survivin Inhibitor YM155 || YM-155"	SEPANTRONIUMBROMIDE	"1HNAPHTH,BROMIDE||SEPANTRONIUMBROMIDE||SEPANTRONIUMBROMIDE||SEPANTRONIUMBROMIDE||SURVIVININHIBITORYM155||YM155"
Serabelisib		"(6-(2-Amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinylmethanone || INK1117 || MLN-1117 || MLN1117 || SERABELISIB || Serabelisib || Serabelisib || TAK 117 || TAK-117"	SERABELISIB	4MORPHOLINYLMETHANONE||INK1117||MLN1117||MLN1117||SERABELISIB||SERABELISIB||SERABELISIB||TAK117||TAK117
siRNA-transfected Peripheral Blood Mononuclear Cells APN401		APN401 || siRNA-transfected PBMC APN401 || siRNA-transfected Peripheral Blood Mononuclear Cells APN401	SIRNATRANSFECTEDPERIPHERALBLOODMONONUCLEARCELLSAPN401	APN401||SIRNATRANSFECTEDPBMCAPN401||SIRNATRANSFECTEDPERIPHERALBLOODMONONUCLEARCELLSAPN401
Sivifene		"4,4'-Dihydroxybenzophenone 2,4-dinitrophenylhydrazone || A-007 || Aryl Hydrazone A-007 Gel || SIVIFENE || Sivifene"	SIVIFENE	"4,4'DIHYDROXYBENZOPHENONE2,4DINITROPHENYLHYDRAZONE||A007||ARYLHYDRAZONEA007GEL||SIVIFENE||SIVIFENE"
Sorafenib		BA4 43 9006 || BAY 43-9006 || BAY 43-9006 || Bay-439006 || SORAFENIB || Sorafenib || Sorafenib || Sorafenib || Sorafenib || sorafenib	SORAFENIB	BA4439006||BAY439006||BAY439006||BAY439006||SORAFENIB||SORAFENIB||SORAFENIB||SORAFENIB||SORAFENIB||SORAFENIB
Sorafenib	Sorafenib Tosylate	4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate || BAY 43-9006 Tosylate || BAY 54-9085 || Nexavar || Nexavar || SORAFENIB TOSYLATE || Sorafenib Tosylate || Sorafenib Tosylate || Sorafenib Tosylate || sorafenib || sorafenib tosylate	SORAFENIBTOSYLATE	4PYRIDINE2CARBOXYLLICACIDMETHYAMIDE4METHYLBENZENESULFONATETOSYLATE||BAY439006TOSYLATE||BAY549085||NEXAVAR||NEXAVAR||SORAFENIBTOSYLATE||SORAFENIBTOSYLATE||SORAFENIBTOSYLATE||SORAFENIBTOSYLATE||SORAFENIB||SORAFENIBTOSYLATE
Staurosporine		"(9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one || (9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one || 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)- || AM-2282 || Antibiotic 230 || Antibiotic AM 2282 || CGP-39360 || STAUROSPORINE || Staurosporine || Staurosporine || staurosporine"	STAUROSPORINE	||AM2282||ANTIBIOTIC230||ANTIBIOTICAM2282||CGP39360||STAUROSPORINE||STAUROSPORINE||STAUROSPORINE||STAUROSPORINE
Sulfate	Larotrectinib Sulfate	"(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid || 1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, Sulfate (1:1) || ARRY 470 Sulfate || LAROTRECTINIB SULFATE || LOXO 101 Sulfate || LOXO-101 Sulfate || Larotrectinib Sulfate || Larotrectinib Sulfate || Vitrakvi"	LAROTRECTINIBSULFATE	||ARRY470SULFATE||LAROTRECTINIBSULFATE||LOXO101SULFATE||LOXO101SULFATE||LAROTRECTINIBSULFATE||LAROTRECTINIBSULFATE||VITRAKVI
Sunitinib		"1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl- || SUNITINIB || Sunitinib || Sunitinib || sunitinib"	SUNITINIB	"1HPYRROLE3CARBOXAMIDE,N2,4DIMETHYL||SUNITINIB||SUNITINIB||SUNITINIB||SUNITINIB"
Sunitinib	Sunitinib Malate	"Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) || SU011248 || SU011248 || SU11248 || SU11248 || SUNITINIB MALATE || Sunitinib Malate || Sunitinib Malate || Sunitinib Malate || Sutent || Sutent || sunitinib || sunitinib malate"	SUNITINIBMALATE	"BUTANEDIOICACID,HYDROXY,||SU011248||SU011248||SU11248||SU11248||SUNITINIBMALATE||SUNITINIBMALATE||SUNITINIBMALATE||SUNITINIBMALATE||SUTENT||SUTENT||SUNITINIB||SUNITINIBMALATE"
Syk Inhibitor HMPL-523		HMPL-523 || Spleen Tyrosine Kinase Inhibitor HMPL-523 || Syk Inhibitor HMPL-523	SYKINHIBITORHMPL523	HMPL523||SPLEENTYROSINEKINASEINHIBITORHMPL523||SYKINHIBITORHMPL523
Tandutinib		"1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)- || CT53518 || CT53518 || MLN 518 || MLN518 || MLN518 || TANDUTINIB || Tandutinib || Tandutinib || tandutinib"	TANDUTINIB	"1PIPERAZINECARBOXAMIDE,4||CT53518||CT53518||MLN518||MLN518||MLN518||TANDUTINIB||TANDUTINIB||TANDUTINIB||TANDUTINIB"
Tanespimycin		"17-(Allylamino)-17-demethoxygeldanamycin || 17-AAG || 17-AAG || 17-AAG || 17-Allylamino-17-demethoxygeldanamycin || 17-Demethoxy-17-(2-propenylamino)geldanamycin || 17-Demethoxy-17-(2-propenylamino)geldanamycin || 17-N-allylamino-17-demethoxy geldanamycin || 17-N-allylamino-17-demethoxygeldanamycin || Geldanamycin, 17-allylamino-17-demethoxy- || KOS-953 || TANESPIMYCIN || Tanespimycin || Tanespimycin || tanespimycin"	TANESPIMYCIN	"17GELDANAMYCIN||17NALLYLAMINO17DEMETHOXYGELDANAMYCIN||17NALLYLAMINO17DEMETHOXYGELDANAMYCIN||GELDANAMYCIN,17ALLYLAMINO17DEMETHOXY||KOS953||TANESPIMYCIN||TANESPIMYCIN||TANESPIMYCIN||TANESPIMYCIN"
Taselisib		GDC-0032 || RO5537381 || TASELISIB || Taselisib || Taselisib	TASELISIB	GDC0032||RO5537381||TASELISIB||TASELISIB||TASELISIB
Tegavivint		"9,10-Anthracenedione, 2,7-bis(((3R,5S)-3,5-dimethyl-1-piperidinyl)sulfonyl)-, 9,10-dioxime, rel- || BC 2059 || BC-2059 || BC2059 || TEGAVIVINT || Tegatrabetan || Tegavivint || Tegavivint"	TEGAVIVINT	"9,10ANTHRACENEDIONE,2,7BIS,9,10DIOXIME,REL||BC2059||BC2059||BC2059||TEGAVIVINT||TEGATRABETAN||TEGAVIVINT||TEGAVIVINT"
Temsirolimus		42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin || CCI-779 || CCI-779 || CCI-779 || CCI-779 Rapamycin Analog || Cell Cycle Inhibitor 779 || Rapamycin Analog || Rapamycin Analog CCI-779 || TEMSIROLIMUS || Temsirolimus || Temsirolimus || Torisel || Torisel || temsirolimus	TEMSIROLIMUS	42RAPAMYCIN||CCI779||CCI779||CCI779||CCI779RAPAMYCINANALOG||CELLCYCLEINHIBITOR779||RAPAMYCINANALOG||RAPAMYCINANALOGCCI779||TEMSIROLIMUS||TEMSIROLIMUS||TEMSIROLIMUS||TORISEL||TORISEL||TEMSIROLIMUS
Tetrahydrouridine		"2(1H)-pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl- || THU || Tetrahydrouridine || Tetrahydrouridine || Tetrahydrouridine || tetrahydrouridine"	TETRAHYDROURIDINE	"2PYRIMIDINONE,TETRAHYDRO4HYDROXY1BETADRIBOFURANOSYL||THU||TETRAHYDROURIDINE||TETRAHYDROURIDINE||TETRAHYDROURIDINE||TETRAHYDROURIDINE"
Thalidomide		"(+)-Thalidomide || (-)-Thalidomide || .alpha.-Phthalimidoglutarimide || 2, 6-Dioxo-3-phthalimidopiperidine || 2,6-Dioxo-3-phthalimidopiperidine || 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione || 3-Phthalimidoglutarimide || Alpha-Phthalimidoglutarimide || Contergan || Contergan || Distaval || Distaval || Kevadon || Kevadon || N-(2,6-Dioxo-3-piperidyl)phthalimide || N-(2,6-Dioxo-3-piperidyl)phthalimide || N-Phthaloylglutamimide || N-Phthaloylglutamimide || N-Phthalylglutamic Acid Imide || N-Phthalylglutamic acid imide || Neurosedyn || Pantosediv || Pantosediv || Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (+)- || Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (-)- || Sedalis || Sedoval K-17 || Softenon || Softenon || Synovir || THALIDOMIDE || Talimol || Talimol || Thalidomide || Thalidomide || Thalidomide || Thalidomide || Thalomid || Thalomid || thalidomide"	THALIDOMIDE	||SEDALIS||SEDOVALK17||SOFTENON||SOFTENON||SYNOVIR||THALIDOMIDE||TALIMOL||TALIMOL||THALIDOMIDE||THALIDOMIDE||THALIDOMIDE||THALIDOMIDE||THALOMID||THALOMID||THALIDOMIDE
Tipifarnib		(+)-6-[Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone || R115777 || R115777 || TIPIFARNIB || Tipifarnib || Tipifarnib || Tipifarnib || Zarnestra || Zarnestra || tipifarnib	TIPIFARNIB	QUINOLINONE||R115777||R115777||TIPIFARNIB||TIPIFARNIB||TIPIFARNIB||TIPIFARNIB||ZARNESTRA||ZARNESTRA||TIPIFARNIB
Tivozanib		"AV-951 || TIVOZANIB || Tivozanib || Tivozanib || Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-"	TIVOZANIB	"AV951||TIVOZANIB||TIVOZANIB||TIVOZANIB||UREA,N[2CHLORO4["
Tozasertib	Tozasertib Lactate	"Aurora Kinase Inhibitor MK-0457 || L-001281814 || MK-0457 || Propanoic acid, 2-hydroxy-, (2S)-, compd. with N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)cyclopropanecarboxamide || TOZASERTIB LACTATE || Tozasertib Lactate || Tozasertib Lactate || VX-680"	TOZASERTIBLACTATE	"AURORAKINASEINHIBITORMK0457||L001281814||MK0457||PROPANOICACID,2HYDROXY,CYCLOPROPANECARBOXAMIDE||TOZASERTIBLACTATE||TOZASERTIBLACTATE||TOZASERTIBLACTATE||VX680"
Trametinib		"GSK1120212 || JTP-74057 || MEK Inhibitor GSK1120212 || Mekinist || N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide || TRAMETINIB || Trametinib || Trametinib"	TRAMETINIB	GSK1120212||JTP74057||MEKINHIBITORGSK1120212||MEKINIST||NACETAMIDE||TRAMETINIB||TRAMETINIB||TRAMETINIB
Trametinib	Trametinib Dimethyl Sulfoxide	TRAMETINIB DIMETHYL SULFOXIDE || Trametinib Dimethyl Sulfoxide || Trametinib Dimethyl Sulfoxide	TRAMETINIBDIMETHYLSULFOXIDE	TRAMETINIBDIMETHYLSULFOXIDE||TRAMETINIBDIMETHYLSULFOXIDE||TRAMETINIBDIMETHYLSULFOXIDE
Trastuzumab		"ABP 980 || ALT02 || Anti-ERB-2 || Anti-HER2/c-erbB2 Monoclonal Antibody || Anti-c-ERB-2 || Anti-c-erbB2 Monoclonal Antibody || Anti-erbB-2 || Anti-erbB2 Monoclonal Antibody || Anti-p185-HER2 || HER2 Monoclonal Antibody || Herceptin || Herceptin || Herceptin Biosimilar PF-05280014 || Herceptin Trastuzumab Biosimilar PF-05280014 || Herzuma || Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman p185(Sup c-erbB2) Receptor), Disulfide with Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer || Kanjinti || MoAb HER2 || Monoclonal Antibody HER2 || Monoclonal Antibody c-erb-2 || Ogivri || Ontruzant || PF-05280014 || RO0452317 || SB3 || TRASTUZUMAB || Trastuzumab || Trastuzumab || Trastuzumab Biosimilar ABP 980 || Trastuzumab Biosimilar ALT02 || Trastuzumab Biosimilar GB221 || Trastuzumab Biosimilar HLX02 || Trastuzumab Biosimilar PF-05280014 || Trastuzumab Biosimilar SB3 || Trastuzumab-anns || Trastuzumab-dkst || Trastuzumab-dttb || Trastuzumab-pkrb || Trastuzumab-qyyp || Trazimera || c-erb-2 Monoclonal Antibody || rhuMAb HER2 || trastuzumab || trastuzumab biosimilar EG12014"	TRASTUZUMAB	"ABP980||ALT02||ANTIERB2||ANTIHER2/CERBB2MONOCLONALANTIBODY||ANTICERB2||ANTICERBB2MONOCLONALANTIBODY||ANTIERBB2||ANTIERBB2MONOCLONALANTIBODY||ANTIP185HER2||HER2MONOCLONALANTIBODY||HERCEPTIN||HERCEPTIN||HERCEPTINBIOSIMILARPF05280014||HERCEPTINTRASTUZUMABBIOSIMILARPF05280014||HERZUMA||IMMUNOGLOBULING1,DISULFIDEWITHHUMANMOUSEMONOCLONALRHUMABHER2LIGHTCHAIN,DIMER||KANJINTI||MOABHER2||MONOCLONALANTIBODYHER2||MONOCLONALANTIBODYCERB2||OGIVRI||ONTRUZANT||PF05280014||RO0452317||SB3||TRASTUZUMAB||TRASTUZUMAB||TRASTUZUMAB||TRASTUZUMABBIOSIMILARABP980||TRASTUZUMABBIOSIMILARALT02||TRASTUZUMABBIOSIMILARGB221||TRASTUZUMABBIOSIMILARHLX02||TRASTUZUMABBIOSIMILARPF05280014||TRASTUZUMABBIOSIMILARSB3||TRASTUZUMABANNS||TRASTUZUMABDKST||TRASTUZUMABDTTB||TRASTUZUMABPKRB||TRASTUZUMABQYYP||TRAZIMERA||CERB2MONOCLONALANTIBODY||RHUMABHER2||TRASTUZUMAB||TRASTUZUMABBIOSIMILAREG12014"
Trastuzumab	Trastuzumab Deruxtecan	DS-8201 || DS-8201a || Enhertu || Fam-trastuzumab Deruxtecan-nxki || TRASTUZUMAB DERUXTECAN || Trastuzumab Deruxtecan || Trastuzumab Deruxtecan || WHO 10516	TRASTUZUMABDERUXTECAN	DS8201||DS8201A||ENHERTU||FAMTRASTUZUMABDERUXTECANNXKI||TRASTUZUMABDERUXTECAN||TRASTUZUMABDERUXTECAN||TRASTUZUMABDERUXTECAN||WHO10516
Trastuzumab	Glycooptimized Trastuzumab-GEX	Ant-HER2 Monoclonal Antibody GT-Mab 7.3-GEX || GT-Mab 7.3-GEX || Glycooptimized Trastuzumab-GEX || TrasGEX	GLYCOOPTIMIZEDTRASTUZUMABGEX	ANTHER2MONOCLONALANTIBODYGTMAB7.3GEX||GTMAB7.3GEX||GLYCOOPTIMIZEDTRASTUZUMABGEX||TRASGEX
Trastuzumab	Lead Pb 212 TCMC-trastuzumab	Lead Pb 212 TCMC-Herceptin || Lead Pb 212 TCMC-trastuzumab || Lead Pb 212 TCMC-trastuzumab || [212]Pb TCMC-Herceptin || [212]Pb TCMC-trastuzumab	LEADPB212TCMCTRASTUZUMAB	LEADPB212TCMCHERCEPTIN||LEADPB212TCMCTRASTUZUMAB||LEADPB212TCMCTRASTUZUMAB||[212]PBTCMCHERCEPTIN||[212]PBTCMCTRASTUZUMAB
Trastuzumab	Trastuzumab Conjugate BI-CON-02	BI-CON-02 || Trastuzumab Conjugate BI-CON-02	TRASTUZUMABCONJUGATEBICON02	BICON02||TRASTUZUMABCONJUGATEBICON02
Trastuzumab	Trastuzumab Duocarmazine	ADC SYD985 || Antibody-drug Conjugate SYD985 || SYD985 || TRASTUZUMAB DUOCARMAZINE || Trastuzumab Duocarmazine || Trastuzumab Duocarmazine || Trastuzumab VC-seco-DUBA || Trastuzumab-drug Conjugate SYD985 || vic-Trastuzumab Duocarmazine	TRASTUZUMABDUOCARMAZINE	ADCSYD985||ANTIBODYDRUGCONJUGATESYD985||SYD985||TRASTUZUMABDUOCARMAZINE||TRASTUZUMABDUOCARMAZINE||TRASTUZUMABDUOCARMAZINE||TRASTUZUMABVCSECODUBA||TRASTUZUMABDRUGCONJUGATESYD985||VICTRASTUZUMABDUOCARMAZINE
Trastuzumab	Ado-Trastuzumab Emtansine	"ADO-TRASTUZUMAB EMTANSINE || ADO-Trastuzumab Emtansine || Ado Trastuzumab Emtansine || Immunoglobulin G1, Anti-(Human p185neu Receptor) (Human-Mouse Monoclonal RhuMab HER2 Gamma1-Chain), Disulfide with Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer, Tetraamide with N2'-(3-((1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)thio)-1-oxopropyl)-N2'-deacetylMaytansine || Kadcyla || PRO132365 || RO5304020 || T-DM1 || Trastuzumab Emtansine || Trastuzumab Emtansine || Trastuzumab-DM1 || Trastuzumab-MCC-DM1 || Trastuzumab-MCC-DM1 Antibody-Drug Conjugate || Trastuzumab-MCC-DM1 Immunoconjugate"	TRASTUZUMABEMTANSINE	"ADOTRASTUZUMABEMTANSINE||ADOTRASTUZUMABEMTANSINE||ADOTRASTUZUMABEMTANSINE||IMMUNOGLOBULING1,ANTIN2'DEACETYLMAYTANSINE||KADCYLA||PRO132365||RO5304020||TDM1||TRASTUZUMABEMTANSINE||TRASTUZUMABEMTANSINE||TRASTUZUMABDM1||TRASTUZUMABMCCDM1||TRASTUZUMABMCCDM1ANTIBODYDRUGCONJUGATE||TRASTUZUMABMCCDM1IMMUNOCONJUGATE"
Trastuzumab	Trastuzumab Monomethyl Auristatin F	ADC FS-1502 || Anti-HER2 ADC FS-1502 || Antibody-drug Conjugate FS-1502 || FS 1502 || FS-1502 || FS1502 || Trastuzumab MMAF || Trastuzumab Monomethyl Auristatin F	TRASTUZUMABMONOMETHYLAURISTATINF	ADCFS1502||ANTIHER2ADCFS1502||ANTIBODYDRUGCONJUGATEFS1502||FS1502||FS1502||FS1502||TRASTUZUMABMMAF||TRASTUZUMABMONOMETHYLAURISTATINF
Trastuzumab	Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502	ADC ADCT-502 || ADCT 502 || ADCT-502 || ADCT502 || Anti-HER2/PBD ADC ADCT 502 || Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 || Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502	TRASTUZUMAB/TESIRINEANTIBODYDRUGCONJUGATEADCT502	ADCADCT502||ADCT502||ADCT502||ADCT502||ANTIHER2/PBDADCADCT502||TRASTUZUMAB/TESIRINEANTIBODYDRUGCONJUGATEADCT502||TRASTUZUMAB/TESIRINEANTIBODYDRUGCONJUGATEADCT502
Trastuzumab	Trastuzumab-TLR 7/8 Agonist BDC-1001	BDC 1001 || BDC-1001 || BDC1001 || ISAC BDC-1001 || Immune Stimulating Antibody Conjugate BDC-1001 || Trastuzumab-TLR 7/8 Agonist BDC-1001 || Trastuzumab-TLR 7/8 Agonist BDC-1001	TRASTUZUMABTLR7/8AGONISTBDC1001	BDC1001||BDC1001||BDC1001||ISACBDC1001||IMMUNESTIMULATINGANTIBODYCONJUGATEBDC1001||TRASTUZUMABTLR7/8AGONISTBDC1001||TRASTUZUMABTLR7/8AGONISTBDC1001
Tretinoin		"(All-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid || 2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)- || ATRA || ATRA || Aberel || Aberel || Airol || Airol || Aknoten || Aknoten || All-trans Retinoic Acid || All-trans Vitamin A Acid || Avita || Avita || Cordes Vas || Dermairol || Dermairol || Epi-Aberel || Eudyna || Eudyna || Renova || Renova || Retin-A || Retin-A || Retin-A || Retin-A MICRO || Retin-A-Micro || Retinoic Acid || Retisol-A || Ro 5488 || Stieva-A || Stieva-A Forte || TRETINOIN || Trans Retinoic Acid || Trans Vitamin A Acid || Tretinoin || Tretinoin || Tretinoin || Tretinoin || Tretinoin || Tretinoinum || Vesanoid || Vesanoid || Vitamin A Acid || Vitamin A acid || Vitamin A acid, all-trans- || Vitinoin || all trans-Retinoic acid || all-trans retinoic acid || all-trans-Retinoic acid || all-trans-Vitamin A acid || beta-Retinoic Acid || retinoic acid || trans-Retinoic Acid || trans-Retinoic acid || tretinoin || vitamin A acid"	TRETINOIN	"||ATRA||ATRA||ABEREL||ABEREL||AIROL||AIROL||AKNOTEN||AKNOTEN||ALLTRANSRETINOICACID||ALLTRANSVITAMINAACID||AVITA||AVITA||CORDESVAS||DERMAIROL||DERMAIROL||EPIABEREL||EUDYNA||EUDYNA||RENOVA||RENOVA||RETINA||RETINA||RETINA||RETINAMICRO||RETINAMICRO||RETINOICACID||RETISOLA||RO5488||STIEVAA||STIEVAAFORTE||TRETINOIN||TRANSRETINOICACID||TRANSVITAMINAACID||TRETINOIN||TRETINOIN||TRETINOIN||TRETINOIN||TRETINOIN||TRETINOINUM||VESANOID||VESANOID||VITAMINAACID||VITAMINAACID||VITAMINAACID,ALLTRANS||VITINOIN||ALLTRANSRETINOICACID||ALLTRANSRETINOICACID||ALLTRANSRETINOICACID||ALLTRANSVITAMINAACID||BETARETINOICACID||RETINOICACID||TRANSRETINOICACID||TRANSRETINOICACID||TRETINOIN||VITAMINAACID"
Tretinoin	Tretinoin Liposome	AR-623 || All-trans-retinoic acid liposomal || Atragen || Liposomal all-trans-retinoic acid || Liposomal tretinoin || Tretinoin Liposomal || Tretinoin Liposome || TretinoinLF	TRETINOINLIPOSOME	AR623||ALLTRANSRETINOICACIDLIPOSOMAL||ATRAGEN||LIPOSOMALALLTRANSRETINOICACID||LIPOSOMALTRETINOIN||TRETINOINLIPOSOMAL||TRETINOINLIPOSOME||TRETINOINLF
Trioxifene		"(3,4-Dihydro-2-(4-methoxyphenyl)-1-naphthalenyl)(4-(2-(1-pyrrolidinyl)ethoxy)phenyl) Methanone || TRIOXIFENE || Trioxifene"	TRIOXIFENE	METHANONE||TRIOXIFENE||TRIOXIFENE
Tyrosine Kinase Inhibitor SU5402		3-[(3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene]-2-indolinone || SU 5402 || Tyrosine Kinase Inhibitor SU5402	TYROSINEKINASEINHIBITORSU5402	3[METHYLENE]2INDOLINONE||SU5402||TYROSINEKINASEINHIBITORSU5402
UAE Inhibitor TAK-243		AOB87172 || MLN7243 || TAK-243 || TAK-243 || UAE Inhibitor  TAK-243 || UAE Inhibitor TAK-243	UAEINHIBITORTAK243	AOB87172||MLN7243||TAK243||TAK243||UAEINHIBITORTAK243||UAEINHIBITORTAK243
Ubidecarenone	Ubidecarenone Nanodispersion BPM31510n	BP31510 || Coenzyme Q10 Injectable Nanosuspension || Ubidecarenone Injectable Nanosuspension || Ubidecarenone Nanodispersion BPM31510n || Ubiquinone Injectable Nanosuspension	UBIDECARENONENANODISPERSIONBPM31510N	BP31510||COENZYMEQ10INJECTABLENANOSUSPENSION||UBIDECARENONEINJECTABLENANOSUSPENSION||UBIDECARENONENANODISPERSIONBPM31510N||UBIQUINONEINJECTABLENANOSUSPENSION
Vadimezan		"5,6-Dimethylxanthenone-4-Acetic Acid || 5,6-MexXAA || ASA404 || DMXAA || Dimethyloxoxanthene Acetic Acid || Dimethylxanthenone Acetic Acid || VADIMEZAN || Vadimezan || Vadimezan || dimethylxanthenone acetic acid"	VADIMEZAN	"5,6DIMETHYLXANTHENONE4ACETICACID||5,6MEXXAA||ASA404||DMXAA||DIMETHYLOXOXANTHENEACETICACID||DIMETHYLXANTHENONEACETICACID||VADIMEZAN||VADIMEZAN||VADIMEZAN||DIMETHYLXANTHENONEACETICACID"
Vandetanib		AZD6474 || Caprelsa || VANDETANIB || Vandetanib || Vandetanib || Vandetanib || ZD-6474 || ZD6474 || ZD6474 || Zactima || Zactima || vandetanib	VANDETANIB	AZD6474||CAPRELSA||VANDETANIB||VANDETANIB||VANDETANIB||VANDETANIB||ZD6474||ZD6474||ZD6474||ZACTIMA||ZACTIMA||VANDETANIB
Vandetanib	Vandetanib-eluting Radiopaque Bead BTG-002814	BTG-002814 || VERB || VERB BTG-002814 || VTB-loaded Beads || Vandetanib-eluting Radiopaque Bead BTG-002814 || Vandetanib-eluting Radiopaque Embolic Beads	VANDETANIBELUTINGRADIOPAQUEBEADBTG002814	BTG002814||VERB||VERBBTG002814||VTBLOADEDBEADS||VANDETANIBELUTINGRADIOPAQUEBEADBTG002814||VANDETANIBELUTINGRADIOPAQUEEMBOLICBEADS
Vatalanib		CGP 79787 || CGP-79787 || N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine || PTK787 || PTK787/ZK 222584 || VATALANIB || Vatalanib || Vatalanib || ZK-232934 || vatalanib	VATALANIB	CGP79787||CGP79787||N1PHTHALAZINAMINE||PTK787||PTK787/ZK222584||VATALANIB||VATALANIB||VATALANIB||ZK232934||VATALANIB
Vatalanib	Vatalanib Succinate	"1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate || Butanedioic Acid, Compd. with N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1) || CGP 79787D || PTK 787 || PTK-787 || PTK787 || VATALANIB SUCCINATE || Vatalanib Succinate || ZK 222584"	VATALANIBSUCCINATE	"1[4CHLOROANILINO]4[4PYRIDYLMETHYL]PHTHALAZINESUCCINATE||BUTANEDIOICACID,COMPD.WITHN||CGP79787D||PTK787||PTK787||PTK787||VATALANIBSUCCINATE||VATALANIBSUCCINATE||ZK222584"
Vemurafenib		"1-propanesulfonamide, n-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)- || BRAF (V600E) kinase inhibitor RO5185426 || BRAF(V600E) Kinase Inhibitor RO5185426 || PLX-4032 || PLX4032 || RG 7204 || RG7204 || RG7204 || RO 5185426 || VEMURAFENIB || Vemurafenib || Vemurafenib || Zelboraf"	VEMURAFENIB	"1PROPANESULFONAMIDE,NKINASEINHIBITORRO5185426||PLX4032||PLX4032||RG7204||RG7204||RG7204||RO5185426||VEMURAFENIB||VEMURAFENIB||VEMURAFENIB||ZELBORAF"
Venetoclax		"4-(4-((2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide || ABT-0199 || ABT-199 || ABT199 || GDC-0199 || RG7601 || VENETOCLAX || Venclexta || Venclyxto || Venetoclax || Venetoclax"	VENETOCLAX	4BENZAMIDE||ABT0199||ABT199||ABT199||GDC0199||RG7601||VENETOCLAX||VENCLEXTA||VENCLYXTO||VENETOCLAX||VENETOCLAX
Vinorelbine		"3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine || 5'-Nor-Anhydrovinblastine || Dihydroxydeoxynorvinkaleukoblastine || VINORELBINE || Vinorelbine || Vinorelbine || nor-5'-Anhydrovinblastine || vinorelbine"	VINORELBINE	"3',4'DIDEHYDRO4'DEOXYC'NORVINCALEUKOBLASTINE||5'NORANHYDROVINBLASTINE||DIHYDROXYDEOXYNORVINKALEUKOBLASTINE||VINORELBINE||VINORELBINE||VINORELBINE||NOR5'ANHYDROVINBLASTINE||VINORELBINE"
Vinorelbine	Liposomal Vinorelbine	Liposomal Vinorelbine	LIPOSOMALVINORELBINE	LIPOSOMALVINORELBINE
Vinorelbine	Vinorelbine Tartrate	Biovelbin || Eunades || KW-2307 || NVB || Navelbine || Navelbine || Navelbine Ditartrate || Navelbine ditartrate || VINORELBINE TARTRATE || Vinorelbine Ditartrate || Vinorelbine Tartrate || Vinorelbine Tartrate || vinorelbine tartrate	VINORELBINETARTRATE	BIOVELBIN||EUNADES||KW2307||NVB||NAVELBINE||NAVELBINE||NAVELBINEDITARTRATE||NAVELBINEDITARTRATE||VINORELBINETARTRATE||VINORELBINEDITARTRATE||VINORELBINETARTRATE||VINORELBINETARTRATE||VINORELBINETARTRATE
Vinorelbine	Vinorelbine Tartrate Emulsion	ANX-530 || Vinorelbine Tartrate Emulsion || Vinorelbine Tartrate Emulsion || Vinorelbine Tartrate Injectable Emulsion	VINORELBINETARTRATEEMULSION	ANX530||VINORELBINETARTRATEEMULSION||VINORELBINETARTRATEEMULSION||VINORELBINETARTRATEINJECTABLEEMULSION
Vinorelbine	Vinorelbine Tartrate Oral	Vinorelbine Tartrate Oral	VINORELBINETARTRATEORAL	VINORELBINETARTRATEORAL
Vismodegib		2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide || Erivedge || GDC-0449 || GDC-0449 || Hedgehog Antagonist GDC-0449 || VISMODEGIB || Vismodegib || Vismodegib	VISMODEGIB	2CHLORON[4CHLORO3BENZAMIDE||ERIVEDGE||GDC0449||GDC0449||HEDGEHOGANTAGONISTGDC0449||VISMODEGIB||VISMODEGIB||VISMODEGIB
Vistusertib		"AZD 2014 || AZD-2014 || AZD2014 || Benzamide, 3-(2,4-Bis((3S)-3-methyl-4-morpholinyl)pyrido(2,3-d)pyrimidin-7-yl)-N-methyl- || VISTUSERTIB || Vistusertib || Vistusertib"	VISTUSERTIB	"AZD2014||AZD2014||AZD2014||BENZAMIDE,3NMETHYL||VISTUSERTIB||VISTUSERTIB||VISTUSERTIB"
Volasertib		"BI 6727 || BI-6727 || Benzamide, N-(Trans-4-(4-(Cyclopropylmethyl)-1-Piperazinyl)Cyclohexyl)-4-(((7r)-7-Ethyl-5,6,7,8-Tetrahydro-5-Methyl-8-(1-Methylethyl)-6-Oxo-2-Pteridinyl)Amino)-3-Methoxy- || Polo-like Kinase 1 Inhibitor BI 6727 || VOLASERTIB || Volasertib || Volasertib"	VOLASERTIB	"BI6727||BI6727||BENZAMIDE,N3METHOXY||POLOLIKEKINASE1INHIBITORBI6727||VOLASERTIB||VOLASERTIB||VOLASERTIB"
Vorinostat		L-001079038 || MSK-390 || N-Hydroxy-N'-phenyloctanediamide || SAHA || SAHA || Suberanilohydroxamic Acid || Suberanilohydroxamic Acid || Suberoylanilide Hydroxamic Acid || VORINOSTAT || Vorinostat || Vorinostat || Zolinza || Zolinza || suberoylanilide hydroxamic acid || vorinostat	VORINOSTAT	L001079038||MSK390||NHYDROXYN'PHENYLOCTANEDIAMIDE||SAHA||SAHA||SUBERANILOHYDROXAMICACID||SUBERANILOHYDROXAMICACID||SUBEROYLANILIDEHYDROXAMICACID||VORINOSTAT||VORINOSTAT||VORINOSTAT||ZOLINZA||ZOLINZA||SUBEROYLANILIDEHYDROXAMICACID||VORINOSTAT
Zebularine		1-beta-D-Ribofuranosyl-2(1H)-pyrimidinone || 2-Pyrimidone-1-beta-D-riboside || Pyrimidin-2-one beta-Ribofuranoside || Zebularine || Zebularine	ZEBULARINE	1BETADRIBOFURANOSYL2PYRIMIDINONE||2PYRIMIDONE1BETADRIBOSIDE||PYRIMIDIN2ONEBETARIBOFURANOSIDE||ZEBULARINE||ZEBULARINE